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ABSTRACT

Kim, Yeji. Ph.D., Purdue University, December 2014. Modulating Cell Differentiation
with Protein-Engineered Microenvironments. Major Professor: Julie C. Liu.

Tissue damage caused by diseases and injuries requires regeneration to recover
proper tissue function. Traditional treatments using autologous tissue have not yet met
the need for tissue regeneration. Tissue engineering has emerged as an alternative
strategy for tissue regeneration. It utilizes biomaterials that mimic native cellular
microenvironments and provide environmental cues to induce specific cell responses,
including differentiation. Biochemical and biophysical cues modulate cell behavior and
direct construction of specific types of tissue. Thus, this work describes production and
characterization of protein-engineered microenvironments that provide biochemical and
biophysical cues to modulate stem cell differentiation.
We created modular proteins containing two domains, a resilin structural domain
and bioactive domains. The resilin domain (RZ) includes ten repeats of a resilin-like
sequence, which are derived from the African malaria mosquito and provide mechanical
integrity. Depending on the targeted cell response, the bioactive domains include peptide
sequences derived from growth factors or extracellular matrix proteins. Proteinengineered microenvironments were created as adsorbed protein layers or crosslinked
matrices.
First, we produced RZ-BMP proteins containing a peptide derived from bone
morphogenetic protein-2 (BMP-2 peptide) and examined the effect of this biochemical
cue on osteogenic differentiation of human mesenchymal stem cells (hMSCs). Cells
cultured on the RZ-BMP proteins had increased levels of osteogenic markers, such as
alkaline phosphatase activity, calcium deposition, and expression of bone-related genes.

xi
Our results show that, within the context of our proteins, the BMP-2 peptide was active
and accelerated osteogenic differentiation of hMSCs. We also examined whether there is
a synergistic effect of the BMP-2 peptide and the RGD cell-binding sequence on
osteogenic differentiation but found that there was no synergy within the context of our
proteins.
Next, we switched the biochemical cue in our microenvironments to achieve a
different type of cell differentiation. Instead of the BMP-2 peptide, a peptide derived
from vascular endothelial growth factor (QK peptide) was included in the RZ-QK protein
to induce endothelial differentiation. We demonstrated that endothelial differentiation of
hMSCs was achieved on the RZ-QK proteins in the absence of exogenous growth factors
as the RZ-QK proteins promoted endothelial-specific markers and endothelial functions.
In particular, cells on our proteins exhibited statistically equivalent network formation as
positive control cells.
Finally, we evaluated the effect of biophysical cues (i.e., matrix stiffness) on cell
responses such as spreading and endothelial differentiation. We used proteins containing
the RGD cell-binding sequence to promote cell adhesion. The proteins were crosslinked
with transglutaminase (TGase) to create RZ-TGase matrices with varying stiffness, and
the stiffness of our matrices was similar to that of subendothelial environments. The
matrix stiffness modulated spreading and endothelial differentiation of hMSCs as the
stiffest matrices promoted greater cell spreading and higher endothelial function
compared to the softest matrices. Of particular note, our RZ-TGase matrices promoted
statistically equivalent endothelial function as hard surfaces, which are routinely used for
conventional cell differentiation but are much stiffer than the subendothelial matrix. Thus,
our tunable matrix system is a promising tool to provide more native subendothelial
environments compared to conventional hard culture substrates.
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CHAPTER 1. INTRODUCTION

1.1

Overview of Tissue Engineering

Tissue damage caused by diseases and injuries requires regeneration to recover
proper tissue function. Traditionally, severe defects in tissues and organs have been
treated by transplantation of tissue obtained from human or animals. However,
autologous tissues from the patient‘s body have significant disadvantages such as limited
availability of donor tissue, chronic donor site pain, and additional surgery for harvesting
donor tissue. In contrast, the use of allogeneic (i.e., tissues from the same species) or
xenographic (i.e., tissue from animals) tissues for regeneration is limited by possible
disease transmission from donor to recipient and by the immune response after
implantation. Due to these limitations, traditional treatments have not yet met the need
for tissue regeneration. In 2007, the number of people in the waiting list for an organ was
100,000, while 6,300 patients who had been on the list died [1].
Tissue engineering has emerged as an alternative strategy for tissue regeneration as
it overcomes drawbacks associated with traditional regeneration methods. Engineered
tissues can be produced with autologous cells to reduce immunogenicity issues and
scaled up to satisfy increasing demands. Tissue engineering utilizes biomaterials that can
be manufactured by applying concepts in the field of engineering, material science, and
cell biology. The biomaterials are intended to mimic native cellular microenvironments
and provide environmental cues to induce specific cell responses such as proliferation,
migration, differentiation, and eventually tissue regeneration. Among environmental cues,
biophysical and biochemical cues have been used and investigated in many studies to
modulate cell behavior. For example, matrix stiffness and growth factors have been
incorporated to engineered biomaterials with stem cells to guide bone and blood vessel
formation.

2
1.2

Components of Engineered Tissue

To mimic architecture found in native bone and vascular tissues, engineered
tissues consist of cells, scaffolds, and environmental cues, which would work in concert
to accelerate tissue regeneration upon implantation.

Cells:
Cells are incorporated into engineered scaffolds to produce and maintain
extracellular matrix (ECM). Autologous cells would be the gold standard as they already
exhibit desired functional characteristics and avoid immunogenicity issues. However,
generally it is difficult to obtain autologous cells in large quantities.
Mesenchymal stem cells (MSCs) have been widely used for bone and vascular
tissue engineering. They can be easily isolated from bone marrow and expanded in vitro.
The Friedenstein group was the first to provide evidence of the osteogenic (bone-forming)
potential of MSCs [2], and Bruder et al. showed the use of MSCs in repairing bone
defects in large animals [3]. However, in vivo bone formation of MSCs remains quite
unpredictable due to a relatively low commitment towards the osteogenic lineage [4].
Therefore, the use of bioactive cues such as dexamethasone (100 nM) [5] or growth
factors (e.g., bone morphogenetic proteins (BMPs)) has been proposed to overcome the
problem.
MSCs also have the potential to differentiate towards other lineages such as
adipogenic, neurogenic, and endothelial lineages. In particular, in vitro endothelial
differentiation of MSCs was demonstrated by Oswald et al [6]. When cultured with
biochemical cues (i.e., vascular endothelial growth factor (VEGF)), MSCs showed a
substantial expression of endothelial-specific markers such as VEGF receptors (KDR and
VEGFR-1) and von Willebrand factor (vWF). In addition, endothelial differentiation of
MSCs has been achieved by several different culture conditions such as serum
deprivation [7] and high cell plating density [8].
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Scaffolds:
Scaffolds act as a temporary matrix while new tissue is regenerated. They provide
mechanical support; a suitable environment that allows cells to attach, migrate,
proliferate, and differentiate for new tissue formation; and reservoirs for nutrients,
cytokines, and growth factors.
Various materials have been developed as bone scaffolds, including bioactive
inorganic materials, polymers, and composite materials. Bioactive inorganic materials
such as hydroxyapatite (HA) and tricalciumphosphate (TCP) are similar in composition
to that of the mineral phase in native bone, but they are too brittle to be used in loadbearing sites [9]. Synthetic polymers such as polylactic acid (PLA), polyglycolic acid
(PGA), copolymers of PLA and PGA (PLGA), and polycaprolactone (PCL) can be
processed into different sizes and shapes and modified to change their physical and
chemical properties [10]. Nevertheless, their applications are limited by inflammatory
responses to degradation products. In addition, in order to mimic the composite nature of
native bone, polymer/inorganic composite materials such as PLGA/HA have been studied.
However, the mechanical integrity of current composites is still lower than that of cortical
or cancellous bone [11].
Vascular scaffolds have been constructed using different materials. Synthetic grafts
such as poly(ethylene terephthalate) (PET) and expanded poly(tetrafluoroethylene)
(ePTFE) have been clinically employed [12]. Because PET and ePTFE cannot be
resorbed, the use of PLGA and PCL scaffolds has been proposed for vessel
reconstruction because of their biodegradability [13]. In addition, collagen- and fibrinbased vessel scaffolds can promote cell attachment and cellular signaling, but they are not
mechanically robust enough to withstand blood pressure [13]. In contrast, decellularized
scaffolds such as small intestinal submucosa (SIS) exhibit better compliance compared to
PET and ePTFE [14], but their application for vessel regeneration is hampered by
potential immunogenicity issues.
Alternatively,

genetically

engineered

protein-based

biomaterials

have

been

considered as potential scaffolds for bone and vascular tissue engineering applications.
The desired peptide motifs can be encoded into DNA and expressed in a bacterial system.
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Because genetic engineering allows incorporation of multiple peptide motifs into one
material, production is relatively simple and material properties can be easily tuned. Also,
recombinant protein reduces concerns about immunogenicity and disease transmission
resulting from the use of natural protein.
As an example of protein-based biomaterials, recombinant collagen has been shown
to direct mineralization by formation of HA crystals [15], and these mineralized
collagens promoted regeneration in rabbit bone defects [16]. Spider silk-silica fusion
protein scaffolds promoted growth and osteogenic differentiation of human MSCs [17].
Several attempts have also been made to construct protein-based scaffolds for vascular
tissue engineering. Recombinant tropoelastin and elastin-like polypeptides scaffolds
supported proliferation of smooth muscle cells [18] and human umbilical vein endothelial
cells [19], respectively.

Environmental Cues:
In native tissue, cells are surrounded by microenvironmental cues that affect cell
behavior. The cues are classified into four different types, biochemical cues (e.g., growth
factors and ligands), biophysical cues (e.g., stiffness, topography, and shear stress or
strain), extracellular matrix proteins (i.e., collagen, laminin, proteoglycans, and
fibronectin), and cell-to-cell interaction (i.e., Notch signaling and cadherins) [20]. Among
the cues, growth factors and stiffness have been widely employed into engineered tissues
to mimic native microenvironments and induce desired cell responses.
Growth factors and ECM ligands are molecules that influence specific cellular
function by binding to receptors present in the cell membrane. BMPs are known to
induce osteogenic differentiation of stem cells [21]. VEGF is utilized to promote
endothelial differentiation of MSCs [6] and modulate arterial or venous specification of
human MSCs [22]. The small peptide sequences derived from BMP-2 (i.e., BMP-2
peptide) and VEGF (i.e., QK peptide) were reported to mimic the function of full-length
BMP-2 and VEGF, respectively [23, 24]. The peptide arginine-glycine-aspartic acid
(RGD) is a well-known ECM ligand that supports cell adhesion.
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These biochemical cues have been incorporated into scaffolds to localize cue
concentration and enable prolonged signaling. Several studies demonstrated that the
BMP-2 peptide incorporated into scaffolds promoted osteogenic differentiation of MSCs
and has a synergistic effect with RGD on osteogenic differentiation [25-28]. The QKincorporated scaffolds promoted proliferation and function of endothelial cells [29-33].
The stiffness of the matrix or scaffold where cells are grown has been shown to
modulate cell behavior. Previous reports showed that stem cell fate can be determined by
stiffness of two-dimensional (2D) and three-dimensional (3D) microenvironments. For
example, osteogenic differentiation of MSCs occurred on 2D substrate with a stiffness of
25-40 kPa [34] and in a 3D matrix with a 11-30 kPa [35]. In addition, mature endothelial
cells on or in gels of varying stiffnesses exhibited different migration behavior [36],
network formation [37], and sprouting and outgrowth [38].
Furthermore, it was suggested that the interplay of biochemical cues and material
stiffness direct cell differentiation. One study reported that osteogenic differentiation with
full-length BMP-2 was enhanced when matrix stiffness increased from 1 to 32 kPa.
Another study demonstrated that the BMP-2 peptide on a stiff matrix of 45-49 kPa
enhanced osteogenic differentiation of human MSCs, whereas the peptide on a soft
matrix of 1-3 kPa had no effect on osteogenic differentiation [39]. For endothelial
differentiation, a combination of matrix stiffness and VEGF had a synergistic effect on
MSC differentiation, as a matrix of 2 kPa and VEGF improved cell differentiation
compared to the matrix or VEGF alone [40].
1.3

Modular Protein Design

For this thesis, we designed modular proteins that provide human MSCs
microenvironmental cues to promote specific responses such as cell adhesion and
differentiation. Using modular proteins, engineered microenvironments were created as
adsorbed protein layers or crosslinked matrices.
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Affinity tag with
cleavable site

Structural
Bioactive
Potential
repeats crosslinking sites domain

Protein

Bioactive domain

RZ-BMP:

KIPKASSVPTELSAIST LYL

RZ-scBMP: LILSLATSPIATVSKYPSKE
RZ-QK:
RZ-scQK:

GGGKLTWQELYQLKYKGIGG
GGGWYEKLGKIYKTLQLQGG

RZ-RGD: GGTVYAVTGRGDSPASSGGG
RZ-scRGD: GGTVYAVTGRDGSPASSGGG

AQTPSSKQFGAPAQTPSSQFGAP

Figure 1.3.1. Resilin-based modular proteins used in this thesis. Proteins consist of two
different domains. The structural domain contains ten repeats of a resilin-like sequence
(red) and potential crosslinking sites (black). The bioactive domain (blue) contains the
BMP-2 peptide (for the RZ-BMP protein in Chapter 2), the QK peptide (for the RZ-QK
protein in Chapter 3), or the RGD sequence (for the RZ-RGD protein in Chapter 4),
depending on the intended cellular responses. A cleavable tag (purple) is included for
protein identification and purification. The RZ-scBMP, RZ-scQK, and RZ-scRGD
proteins serve as sequence-scrambled negative control proteins.
The proteins consist of two domains, structural and bioactive domains, as shown in
Figure 1.3.1. The resilin structural domain, referred to as RZ, includes ten repeats of a
resilin-like sequence (AQTPSSQYGAP) derived from the African malaria mosquito
Anopheles gambiae and provides mechanical integrity. The sequence in the resilin
domain has amino acids that offer crosslinking sites. First, a lysine (K) residue is
included next to a glutamine (Q) residue once every two resilin repeats to provide a
crosslinking site. The lysine residues can be crosslinked by the amine reactive crosslinker
tris(hydroxymethyl)phosphine (THP). It was reported that the THP-mediated crosslinking
reaction releases only water [41]. Second, the glutamine (Q) and lysine (K) residues in
the resilin domain can be utilized for transglutaminase-mediated crosslinking sites as the
enzyme forms covalent bonds between Q and K [42]. Third, the tyrosine (Y) residue in
the original resilin sequence was replaced by phenylalanine (F) to serve as a potential
crosslinking site. A bacterial host that harbors a mutated phenylalanyl tRNA synthetase
can incorporate the non-natural amino acid para-azido phenylalanine into phenylalanine
sites [43]. UltraViolet (UV) light can be used to crosslink p-azido phenylalanine residues.
Each resilin-based modular protein contains a different biochemical cue such as 1)
the BMP-2 peptide for the RZ-BMP protein (Chapter 2), 2) the QK peptide for the RZQK protein (Chapter 3), or 3) the RGD cell-binding sequence for the RZ-RGD protein
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(Chapter 4). Briefly, the BMP-2 and QK peptides are intended to promote osteogenic and
endothelial differentiation as they mimic the function of full-length BMP-2 and VEGF,
respectively [24, 44]. The RGD sequence is incorporated to enhance cell adhesion. In
order for each protein to have approximately the same length and molecular weight, five
glycine residues (G) are placed on either side of the QK and RGD sequences. Each
protein includes tags on the N-terminus – a T7 tag for protein identification, a
heptahistidine (His) tag for protein purification, and an enterokinase cleavage site for
removal of the tags.

Resilin:
Resilin is one of the elastomeric proteins present in the insect cuticle. It exhibits
high resilience [45] and a very high fatigue lifetime [46]. It plays a significant role in the
jumping mechanism of fleas [47], the flight system of locusts [48], leg movement in
arachnids [49], and sound production in cicadas [50]. Similar to other elastic proteins,
resilin has repetitive sequences. The soluble precursor of resilin (pro-resilin) contains
tyrosine residues that can be crosslinked to generate di- and tri-tyrosines linkages,
thereby forming a three-dimensional network [51].
Resilin-based recombinant proteins have been produced to potentially serve as
scaffolds for tissue engineering applications. In one study, a putative resilin gene
(CG15920) within Drosophila melanogaster (fruitfly) was identified [52], and
recombinant protein containing the first exon of this gene (i.e., rec1-resilin) was cloned
and expressed as a soluble form in Escherichia coli [53]. The resilin sequence from D.
melanogaster has been used and studied for vocal fold regeneration [54] and
cardiovascular tissue engineering [55]. In addition, recombinant resilin protein, which
includes resilin sequences from A. gambiae, displayed similar mechanical properties to
rec1-resilin [56] and was examined for cartilage tissue engineering [57].
Resilin-based proteins have been functionalized for versatile cellular functions.
The Kiick group introduced three types of bioactive peptides to resilin-based proteins; the
RGD cell-binding sequence for cell adhesion, a matrix metalloproteinase (MMP)
sensitive sequence for proteolytic degradation, and a heparin-binding domain for the
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sequestration and controlled release of growth factors such as VEGF and basic fibroblast
growth factor (FGF) [54, 55, 58]. They demonstrated that proteins supported cell
attachment and adhesion by RGD and were enzymatically degradable due to the MMPsensitive sequence [54]. Our group included the RGD sequence in resilin-based proteins,
and the proteins promoted cell adhesion [57]. Therefore, functionalization of resilinbased proteins with bioactive peptide motifs can broaden their use for tissue engineering
applications.
1.4

Thesis Outline and Contributions

The goal of this thesis was to create protein-engineered microenvironments to
promote stem cell responses such as adhesion and differentiation. The biochemical and
biophysical cues serve as microenvironmental cues, and the effect of these cues on cell
responses were explored. We show that stem cell differentiation can be modulated by
switching biochemical cues (i.e., bioactive peptide) in resilin-based microenvironments in
Chapter 2 and 3 and by varying biophysical cues (i.e., matrix stiffness) in Chapter 4. For
this document, I produced proteins, planned and performed all experiments, and wrote all
of the chapters unless otherwise stated.
Chapter 2 describes the effect of a biochemical cue (i.e., BMP-2 peptide) on
osteogenic differentiation of human MSCs. The BMP-2 peptide was incorporated into
genetically-engineered resilin protein, and human MSCs were grown on protein surfaces
in osteogenic differentiation medium. Cell differentiation was examined by
characterizing osteogenic markers such as calcium deposition, enzyme activity, and gene
expression. Our data showed that the protein containing the BMP-2 peptide was
cytocompatible and supported cellular metabolic activity. In addition, the BMP-2 peptide
in our protein surface was active and accelerated osteogenic differentiation of human
MSCs compared to the control surface. Dr. Julie N. Renner designed and cloned the
DNA encoding resilin proteins containing the BMP-2 peptide.
Chapter 3 explores the effect of another biochemical cue (i.e., the QK peptide) on
endothelial differentiation of human MSCs. The QK peptide was included in the resilinbased protein, and human MSCs were differentiated on the protein. Endothelial
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differentiation was characterized by evaluating endothelial marker expression and
endothelial functions. Our data demonstrate that endothelial differentiation of human
MSCs was achieved in the absence of exogenous growth factors. Our protein-based
microenvironments supported cell viability and metabolic activity and promoted
endothelial-specific markers and endothelial functions. In particular, cells on our protein
exhibited statistically equivalent network formation to positive control cells.
Chapter 4 describes the effect of matrix stiffness on cell response. The RGD cellbinding sequence was incorporated in the resilin-based protein. The resilin-based protein
matrices were produced by transglutaminase-mediated crosslinking. We demonstrated
that matrix stiffness can be tuned by varying total protein concentration. Our data
demonstrated that the matrix was cytocompatible and supported cell proliferation. In
addition, cell spreading and differentiation were modulated by matrix stiffness as the
stiffest matrices promoted greater cell spreading and higher endothelial differentiation
compared to the softest matrices. Emily E. Gill performed experiments to measure
swelling ratio and water content of the crosslinked resilin matrices.
Chapter 5 describes the summary and major conclusions from this research and
outlines future directions.
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CHAPTER 2. INCORPORATING THE BMP-2 PEPTIDE IN GENETICALLYENGINEERED BIOMATERIALS ACCELERATES OSTEOGENIC
DIFFERENTIATION

This chapter consists of a manuscript by Kim Y, Renner JN, and Liu JC, published in
Biomaterials Science, Volume 2, Issue 8, 2014 - Reproduced by permission of The Royal
Society of Chemistry.

2.1

Abstract

Protein-based biomaterials have emerged as powerful tools for tissue engineering
applications. Recombinant DNA techniques can be used to precisely tune material
properties at the molecular level, and multiple peptide modules can be incorporated into a
single material. Here, we genetically engineered biomaterials that incorporate a peptide
derived from bone morphogenetic protein-2 (BMP-2) and investigated whether the BMP2 peptide, within the context of these materials, can promote stem cells to produce bone
matrix and synergize with a cell-binding sequence (RGD). Our study is the first to
demonstrate that when the BMP-2 peptide is incorporated within the backbone of proteinbased biomaterials, it is active and accelerates osteogenic differentiation of mesenchymal
stem cells. In particular, cells seeded on proteins containing the BMP-2 peptide had
increased levels of alkaline phosphatase (AP) activity, calcium deposition, and expression
of bone-related genes. However, the BMP-2 peptide did not synergize with the RGD cellbinding domain within the context of these protein-based materials. Overall, these results
suggest that incorporation of the BMP-2 peptide within the context of modular proteins is
a successful strategy for engineering biomaterials for applications in bone tissue
engineering.
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2.2

Introduction

Protein-based biomaterials have emerged as promising tissue-engineered
scaffolds. These materials, whose peptide sequences are precisely tuned at the molecular
level, can be manufactured via solid-phase peptide synthesis (SPSS) or genetic
engineering [59]. SPSS is a rapid method to produce short peptides (i.e., 35-40 amino
acids) [60]. Compared to SPSS, genetic engineering allows researchers to create peptides
and proteins with a wide range of sizes. In addition, the longer length of biomaterials
produced by genetic engineering allows for facile incorporation of multiple
functionalities through sequences such as structural (i.e., structural motifs or crosslinking
sites) and bioactive domains (i.e., biochemical factors). For example, recent studies have
utilized elastin-like [43, 61-63], resilin-like [57, 64, 65], and silk-like sequences [17, 66]
as structural domains to provide mechanical properties suitable for specific tissue
engineering applications. In addition, cell-binding sequences [57, 67, 68], heparinbinding sequences [55], and matrix metalloproteinase degradation sites [64] have been
incorporated as bioactive domains to elicit desired cellular responses.
In particular, bioactive domains, such as cues to promote stem cell differentiation,
that are incorporated directly into protein-based biomaterials act as material-based cues
and have a number of advantages over soluble cues. Material-based cues remain at the
target site, whereas soluble growth factors can diffuse away from the target and result in
off-target effects. Thus, material-based differentiation cues would lead to more uniform
differentiation compared to soluble cues, which could result in diffusion gradients and
heterogeneous differentiation. In addition, soluble cues often are utilized at supraphysiological concentrations, which causes side effects [69]. In contrast, attaching a cue
to the material has the potential to lower the overall concentration by effectively
increasing the local surface concentration. Furthermore, differentiation cues such as
growth factors are often bound to the extracellular matrix, and material-based cues mimic
this mode of presentation.
This study investigates the use of material-based cues within the context of
modular proteins that are designed to promote stem cells to produce bone matrix. Our
modular proteins were designed to contain a resilin-like structural domain and a bioactive
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domain (Figure 2.2.1). Our previous work demonstrates that similar materials are
cytocompatible and that when the RGD cell-binding domain was incorporated within the
protein-based materials, it promoted a faster rate of cell spreading compared to the
sequence-scrambled negative control protein [57]. In the current work, we focus on
incorporating a peptide sequence derived from bone morphogenetic protein-2 (BMP-2)
growth factor and examining the ability of this modular protein to induce osteogenic
differentiation.

M-MASMTGGQQMG-HHHHHHH-DDDDK-LDHMRTLS-(AQTPSSKQFGAPAQTPSSQFGAP) -KWADRHGGMR- BA -LE
5

T7 tag

His tag

Cleavage
site

Resilin-based domain (RZ)

Bioactive
domain

BA (Bioactive domain)
RZ-BMP:

KIPKASSVPTELSAISTLYL

RZ-scBMP: LILSLATSPIATVSKYPSKE
RZ-RGD: GGTVYAVTGRGDSPASSGGG
RZ-scRGD: GGTVYAVTGRDGSPASSGGG

Figure 2.2.1 The full amino acid sequences of modular proteins used in this study. At the
N-terminus, each protein has a T7 tag for protein identification, a heptahistidine tag (His
tag) for identification or purification, and an enterokinase cleavage site for removal of the
tags from the modular proteins. The bioactive domain (BA) (indicated by a black bar)
contains one of the sequences listed in the box. For example, the bioactive domain of the
RZ-BMP protein includes the BMP-2 peptide sequence, KIPKASSVPTELSAISTLYL.
The RZ-scBMP and RZ-scRGD proteins serve as sequence-scrambled negative control
proteins.
Human mesenchymal stem cells (hMSCs) derived from the bone marrow have
been extensively used in the field of tissue engineering because they are able to
differentiate into multiple lineages such as bone, cartilage, muscle, and fat [70]. BMP-2
growth factor is one of the most common cues for promoting differentiation of hMSCs
into osteogenic lineages. It has been widely studied in vitro and in vivo in applications of
bone tissue engineering and is being used clinically for bone regeneration [71].
A short peptide sequence derived from the knuckle epitope of BMP-2 (hereafter
referred to as the BMP-2 peptide) was synthesized and shown to have bioactivity similar
to the full-length BMP-2 growth factor; the peptide specifically bound to two types of
BMP receptors [23]. Further studies demonstrated that incorporating the BMP-2 peptide
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in biomaterials induced osteogenic differentiation and ectopic bone formation [25, 26,
72-74] and in vivo bone regeneration [75, 76]. In addition, there was a synergistic effect
on osteogenic differentiation when the BMP-2 peptide and the RGD cell-adhesion
sequence were both incorporated into scaffold materials [25, 27, 28]. Thus, these studies
demonstrated that the BMP-2 peptide was active when incorporated within biomaterials,
but these studies were limited to immobilizing or grafting the sequences on the materials.
Here, we expand the utility of the BMP-2 peptide by demonstrating that it is
bioactive within a new mode of ligand presentation (i.e., within the context of a
genetically-engineered biomaterial). In particular, we utilize genetic engineering to
incorporate the BMP-2 peptide directly into the backbone of our protein-based materials.
Thus, the goal of this study was to investigate the ability of the BMP-2 peptide to
promote osteogenic differentiation of hMSCs when presented within the context of the
backbone of our genetically-engineered biomaterials. To accomplish our goal, we first
used recombinant protein engineering to incorporate the BMP-2 peptide in modular
proteins. Next, we evaluated the metabolic activity of human MSCs on our proteins. Last,
we investigated whether genetically-engineered biomaterials incorporating the BMP-2
peptide enhanced osteogenic differentiation and whether there were synergistic effects
with the RGD cell-binding domain.
2.3

Materials and Methods

Materials:
All materials used in this study were purchased from Sigma-Aldrich unless stated
otherwise.
Material Design:
The DNA constructs were cloned using the methods previously described [77]. In
this study, the proteins consisted of ten repeats of a resilin-like sequence (RZ) derived
from Anopheles gambiae and a bioactive domain (BA). The sequences for the BA
domain are listed in Figure 2.2.1.
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Protein Expression and Purification:
Protein expression was performed as previously described [57]. Briefly, E. coli
strain BL21-CodonPlus (DE3)-RIPL (gift from Dr. Jo Davisson, Purdue University)
containing the desired recombinant plasmid was inoculated in medium containing 35
µg/mL kanamycin and 34 µg/mL chloramphenicol. Small-scale protein expression was
conducted in 4 L baffled flasks, whereas large-scale protein expression was performed in
a fermentor (BioFlo 110, 14 L capacity, New Brunswick). Expression was induced with
isopropyl β-D-1-thiogalactopyranoside (IPTG, Denville Scientific).
Proteins were purified by a salting-out and heating method as previously
described [57, 77]. Briefly, cell pellets were resuspended in 8 M urea (pH 8.0), and cells
were lysed using freeze-thaw cycles and sonication. After salting out undesired proteins,
the modular proteins were precipitated with 20 (w/v) % ammonium sulfate. The resuspended proteins were heated at 80 °C for 10 min to remove undesired proteins. The
solution was then dialyzed and freeze-dried.
The molecular weight and purity of proteins were confirmed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. Protein purity was
determined by densitometry analysis using Image J software (NIH). The composition of
purified proteins was confirmed by amino acid analysis (Purdue Proteomics Facility at
the Bindley Bioscience Center). The bioactive domain sequences of the RZ-RGD and
RZ-scRGD proteins were confirmed by peptide sequencing (Purdue Proteomics Facility
at the Bindley Bioscience Center). Briefly, the proteins were digested with
endoproteinase AspN, and the fragments were sorted by mass. Fragments from the Cterminus containing the last 11 (RZ-RGD) or 12 (RZ-scRGD) amino acids were further
fragmented into smaller pieces to determine each amino acid sequence.
Surface Preparation:
Protein surfaces were prepared 24 h before cell seeding. Proteins were dissolved
in phosphate-buffered saline (PBS) at 1 mg/mL and adsorbed on tissue culture
polystyrene (TCP) at 4 °C overnight. The next day, the surfaces were washed with PBS
three times to remove unbound proteins. Surfaces were blocked with 0.2 (w/v) % bovine
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serum albumin (BSA) (fraction V) that had been heat-inactivated at 85 °C for 10 min.
Blocking was performed for 30 min at room temperature, and then the surface was rinsed
with PBS three times. The density of the proteins adsorbed on TCP was determined
before cell differentiation studies (Figure 2.8.1).
Cell Culture:
To investigate cell responses on the proteins, hMSCs (Lonza) were cultured at 37
°C and 5% CO2 in growth medium consisting of low-glucose Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (Lonza), 100
U/mL penicillin, 100 mg/mL streptomycin (Invitrogen), and 10 ng/mL basic fibroblast
growth factor (bFGF, R&D Systems, courtesy of the National Cancer Institute Preclinical
Repository). Cells were seeded at a density of 5,000-6,000 cells/cm2 and sub-cultured
after they reached 60-80% confluence.
To investigate the bioactivity of our proteins, hMSCs were seeded at a density of
3,100 cells/cm2 on TCP or proteins. After the cells reached 70-85% confluence, they were
cultured in osteogenic medium consisting of growth medium without bFGF and
supplemented with 100 nM dexamethasone, 50 µM ascorbic acid 2-phosphate, and 10
mM glycerol-2-phosphate disodium salt hydrate. The medium was replaced every three
days. All experiments were performed using cells at passages 3-5.
Cellular Metabolic Activity:
Cellular metabolic activity on proteins was measured by monitoring the reduction
of the tetrazolium salt WST-1 (GBioscience). Briefly, 10 µL of the reagent was added to
each well containing 100 µL of the growth medium, and cells were incubated for 4 h at
37 °C. The absorbance of the medium was measured at 440 nm by a SpectraMax M2e
(Molecular Devices) and normalized by the absorbance reading at 600 nm. At each time
point, metabolic activity was determined as the percentage relative to the positive control
(cells on TCP). Six replicates per group were examined.
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Alkaline Phosphatase (AP) Activity:
Culture medium was replaced 24 h prior to cell lysis to prevent serum starvation.
Cells were washed with PBS once and lysed in 0.1 (v/v) % triton in water (pH 7.4) for 15
min at room temperature. Collected cells were frozen at -80 °C before being assayed.
Frozen cells were thawed and centrifuged, and the supernatant was collected. For DNA
quantification, 50 µL of Hoechst 33258 solution (0.7 µg/mL in 50 mM Tris, 100 mM
NaCl, and 0.1 mM EDTA, pH 7.4) was mixed with an equal amount of the supernatant,
and the fluorescence was measured with an excitation at 340 nm and emission at 465 nm.
Calf thymus DNA was used as a standard. For assessment of AP activity, 50 µL of the
supernatant was combined with 50 µL of p-nitrophenol phosphate solution (10 mg/mL in
0.1 M glycine and 1 mM MgCl2, pH 9.6) and incubated at 37 °C for 150 min. The
absorbance was measured at 405 nm, and p-nitrophenol (Alfa Aesar) was used as a
standard. AP activity was normalized by the amount of DNA and incubation time. Three
or four replicates of each group were examined.
Calcium Deposition:
At each time point, cells were fixed with 4 (w/v) % paraformaldehyde in PBS at
room temperature for 15 min and then washed with Milli-Q water (Millipore) three times.
Cells were stained with 40 mM Alizarin red S (pH 4.1) for 40 min at room temperature
with gentle shaking. After Alizarin red S staining, cells were washed with Milli-Q water
five times to remove excess dye. The plates were stored at -20 °C until imaging and dye
extraction. All images were obtained at the same time by using a 4x objective on a Nikon
Ti-EC-1 Plus microscope.
Calcium deposits were quantified by extracting Alizarin red S from the stained
monolayer as previously described.[78] Briefly, stained cells were incubated with 10
(v/v) % acetic acid for 30 min with gentle shaking. The cell solution was heated at 85 °C
for 10 min and then incubated on ice for 5 min. Following centrifugation, the supernatant
was neutralized with 1 (v/v) % ammonium hydroxide to adjust the pH between 4.1 and
4.5. The total amount of extracted dye was determined by measuring the absorbance at
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405 nm. Alizarin red S solutions in acetic acid (pH 4.1-4.5) were used as a standard.
Three to six replicates per group were examined.
Quantitative Reverse Transcription–Polymerase Chain Reaction (qPCR):
The medium was replaced 24 h before sample collection to prevent serum
starvation. Samples were processed and analyzed as previously described [79]. After
removal of genomic DNA, the amount of purified RNA was measured on a Nanodrop
spectrophotometer (ND 1000, Thermo Scientific). At least 0.5 µg RNA was used to
produce complementary DNA. For qPCR, all individual samples were run in duplicate
(day 7 and 11) or triplicate (day 4). The primer sequences for runt-related transcription
factor 2 (Runx2), AP, type I collagen (type I col), osteopontin (OPN), bone sialoprotein
(BSP), type II collagen (type II col), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were obtained from references or designed using Primer-Blast on the National
Institutes of Health website (Table 2.8.1). The relative gene expression level was
calculated by the ∆∆ Ct method; GAPDH was used as the housekeeping gene, and
expression levels were determined relative to the positive control (TCP). There were four
to six replicates per group.
Statistical Analysis:
All data are represented as mean ± standard deviation. Normality and
homogeneity of variance were confirmed by Shapiro-Wilk and Levene’s modified tests,
respectively. For data that passed both tests, one-way analysis of variance (ANOVA) was
performed. Dunnett’s test was performed at each time point to determine significant
differences between the control (TCP) and an experimental group. Statistical differences
between experimental groups were also determined by Tukey’s post hoc test. Data
showing unequal variances (days 9 and 11 in Figure 2.4.3) were analyzed by a Box-Cox
transformation [80]. Data with a non-normal distribution (day 9 in Figure 2.4.4B) were
evaluated by a non-parametric Kruskal-Wallis test. All statistical analyses were
performed using Statistical Analysis Software (SAS, version 9.2), and values of p < 0.05
were considered to be statistically significant.

18
2.4

Results

Material Design, Production, and Characterization:
The full amino acid sequences of proteins used in this study are shown in Figure
2.2.1. Each protein consists of a structural domain to provide mechanical integrity and a
bioactive domain to promote cell differentiation. Ten repeats of a resilin-like consensus
sequence (RZ) derived from A. gambiae, AQTPSSQYGAP, comprised the structural
domain. The bioactive domain included either the BMP-2 peptide (RZ-BMP proteins) or
the cell-binding sequence (RZ-RGD proteins). Proteins containing scrambled versions of
the BMP-2 peptide (RZ-scBMP proteins) or the cell-binding sequence (RZ-scRGD
proteins) served as negative control proteins whose amino acid composition matched
those of the RZ-BMP and RZ-RGD proteins, respectively. Our previous work describes
the manufacture and initial characterization of the RZ-RGD and RZ-scRGD proteins [57].
Thus, this work will describe the production and initial investigation of the RZ-BMP and
RZ-scBMP proteins.

Purified protein
Ladder kDa
58
46

RZ-BMP RZ-scBMP

30
23
17
7
Figure 2.4.1 Successful purification of RZ-BMP and RZ-scBMP proteins. Proteins were
analyzed on an SDS-PAGE gel and appeared close to the expected molecular weight of
18.6 kDa. Densitometry analysis confirmed that the protein samples were > 90% pure.
The average yields of purified RZ-BMP and RZ-scBMP proteins in small- and
large-scale expressions were 10 and 27 mg per liter of culture, respectively. SDS-PAGE
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analysis confirmed that the RZ-BMP and RZ-scBMP proteins ran near the expected
molecular weight of 18.6 kDa and that the proteins were > 90% pure (Figure 2.4.1).
Amino acid analysis confirmed the compositions of the RZ-BMP and RZ-scBMP
proteins, and the observed value of each component was within 1 mol % of the
anticipated value (Table 2.8.1). Circular dichroism (CD) spectroscopy demonstrated that
the RZ-BMP and RZ-scBMP proteins have an unordered structure (Figure 2.8.2 The
secondary structure of modular proteins evaluated by CD spectroscopy. The results
demonstrated that the RZ-BMP and RZ-scBMP proteins have an unordered structure. CD
spectra were measured using protein solutions at 0.2 mg/mL in Milli-Q water at room
temperature.), which is similar to the structure of the RZ-RGD and RZ-scRGD proteins
previously reported [57].
Human MSC Metabolic Activity on Modular Proteins:
Cellular metabolic activity on proteins was assessed by the WST-1 assay (
Figure 2.4.2). After one day of seeding, it appeared as if fewer cells had attached
to our protein surfaces compared to TCP. In particular, the number of hMSCs on RZBMP and RZ-scBMP proteins was 71 ± 11 and 71 ± 6 %, respectively, compared to those
on the positive control (TCP). However, 2-4 days after seeding, there was no difference
in the metabolic activity of cells grown on TCP or the proteins. These results suggest that
the RZ-BMP and RZ-scBMP proteins are cytocompatible and support hMSC
proliferation at a rate similar to TCP. In subsequent differentiation studies, differentiation
medium was added 4 days after seeding, at which time cell number and metabolic
activity were equivalent on all surfaces.
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Figure 2.4.2 Human MSC metabolic activity on the RZ-BMP and RZ-scBMP proteins.
At each time point, cellular metabolic activity was evaluated by the WST-1 assay, and the
results are presented relative to the positive control (TCP). Cells on all three surfaces had
statistically equivalent metabolic activity 2-4 days after seeding. These results suggest
that the RZ-BMP and RZ-scBMP proteins supported cell proliferation. Data are
represented as the average ± standard deviation of six replicates. * indicates p < 0.05
compared to the positive control (TCP) at that time point as determined by Dunnett’s test.

Presenting the BMP-2 Peptide within the Context of Genetically-engineered Proteins
Accelerates Osteogenic Differentiation:
In examining cell differentiation on our proteins, our first objective was to
determine whether incorporating the BMP-2 peptide within the context of protein-based
biomaterials (RZ-BMP) would enhance osteogenic differentiation compared to control
(TCP). Second, we evaluated whether there were synergistic effects when the BMP-2
peptide and the RGD sequence were individually incorporated within the backbone of the
protein-based materials (RZ-BMP and RZ-RGD proteins, respectively). To accomplish
this goal, we included two additional surfaces in our study – a 50:50 mixture of RZ-BMP
and RZ-scRGD proteins (designated RZ-BMP+RZ-scRGD) and a 50:50 mixture of RZBMP and RZ-RGD proteins (designated RZ-BMP+RZ-RGD). To characterize cell
response on proteins, we examined markers of osteogenic differentiation such as AP
activity, calcium deposition, and gene expression levels.
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AP activity, which is an early marker of osteogenic differentiation, was
characterized by measuring the hydrolysis of p-nitrophenyl phosphate substrate (Figure
2.4.3). At all time points, the AP activity of cells cultured on RZ-BMP was higher than
on the positive control (TCP). Compared to TCP, the RZ-BMP proteins induced a 2-fold
increase at early time points (4 and 7 days) and a 3-fold increase at later time points (9
and 11 days). However, cells cultured on the sequence-scrambled negative control RZscBMP protein did not enhance AP activity compared to cells on TCP. Of particular note,
cells on RZ-BMP had statistically higher AP activity compared to cells on RZ-scBMP at
all time points (p < 0.05, Tukey’s post hoc test). Therefore, our results indicate that the
RZ-BMP proteins effectively enhance AP activity in a sequence-specific manner.

ng p-nitrophenol/ng DNA/min

1.6

1.2

TCP
RZ-scBMP
RZ-BMP
RZ-BMP+RZ-scRGD
RZ-BMP+RZ-RGD

*

*

0.8

*

**
0.4

*

**

0
4

7

9

11

Time (Days)

Figure 2.4.3 Presenting the BMP-2 peptide within the context of genetically-engineered
materials (RZ-BMP or RZ-BMP+RZ-scRGD proteins) enhances the AP activity of cells.
Compared to cells on TCP, cells grown on RZ-BMP or RZ-BMP+RZ-scRGD proteins
showed increased AP activity at all time points, whereas those on RZ-scBMP or RZBMP+RZ-RGD proteins did not. AP activity was normalized by the DNA amount and
reaction time. Error bars indicate the standard deviation of 3-4 replicates. * indicates p <
0.05 compared to TCP at that time point as determined by Dunnett‘s test.
Cells on RZ-BMP+RZ-scRGD proteins had statistically higher AP activity
compared to cells on TCP at all time points. Also, the AP activity of cells on RZBMP+RZ-scRGD was statistically equivalent to that of cells on RZ-BMP proteins (p <
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0.05, Tukey’s post hoc test). Interestingly, the AP activity of cells on RZ-BMP+RZ-RGD
was not significantly different from those on TCP. Furthermore, from 4 to 9 days of
differentiation, cells cultured on RZ-BMP+RZ-RGD showed a significantly lower AP
activity than those on either RZ-BMP or RZ-BMP+RZ-scRGD (p < 0.05, Tukey’s post
hoc test).
Next, we carried out Alizarin red S staining to examine calcium deposition
(mineralization) of cells cultured on the five different surfaces, and the extent of calcium
deposition was quantified by extracting the dye from the stained monolayer (Figure 2.4.4).
After 9 days of differentiation, no mineralization was observed. However, the amount of
calcium deposited increased from 9 to 11 days of differentiation. After 11 days of
differentiation, cells cultured on RZ-BMP or RZ-BMP+RZ-scRGD exhibited a
significant 3-fold increase in calcium deposition compared to those on TCP. However,
the RZ-BMP+RZ-RGD proteins did not enhance calcium deposition.
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Figure 2.4.4 Increased calcium deposition by cells grown on modular proteins. (A)
Bright-field images of stained cell monolayers after 11 days of differentiation on TCP or
the proteins. Cells were stained with Alizarin red S, and pictures from three separate
wells are shown for each surface. Scale bar represents 250 µm. (B) Quantification of
Alizarin red S (ARS) staining (n=4-6) was performed by extracting dye from the stained
monolayers. Compared to cells grown on TCP, cells on RZ-BMP and RZ-BMP+RZscRGD proteins showed increased calcium deposition at 11 days of differentiation. *
indicates p < 0.05 compared to TCP at that time point as evaluated by Dunnett‘s test.
Of note, cells grown on the RZ-scBMP proteins showed statistically higher
calcium deposition than those on TCP at day 11. One possible reason for this response is
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that there was more RZ-scBMP adsorbed to the surfaces compared to RZ-BMP, RZBMP+RZ-scRGD, or RZ-BMP+RZ-RGD (Figure 2.8.1B). Due to the higher RZ-scBMP
protein density, the increased number of non-specific interactions with the resilin portion
or with the amino acids within the scrambled domain may have resulted in statistically
higher calcium deposition on RZ-scBMP compared to TCP.
To ensure that our results can be attributed to protein surfaces and are not due to
protein desorbing from the surface, we incubated the RZ-BMP surfaces with medium and
used this pre-conditioned medium in cell differentiation studies. The medium preconditioned on the RZ-BMP proteins did not accelerate osteogenic differentiation
compared to the medium pre-conditioned on TCP (Figure 2.8.3).
Finally, we examined the gene expression level of osteogenic markers by qPCR.
Runx2 is a transcriptional factor involved in osteogenic lineage commitment, whereas AP
and type I col are early- and mid-stage osteogenic markers, respectively. Compared to
control (TCP), cells on RZ-BMP had higher expression levels of Runx2 at 11 days and
type I col at 7 and 11 days (Figure 2.4.5). Although the AP activity was elevated at all
time points when cells were cultured on RZ-BMP (Figure 2.4.3), no increases in gene
expression of AP were observed (Figure 2.4.5). Cells on the RZ-scBMP proteins
generally did not upregulate osteogenic markers except for the expression of type I col at
7 days.
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Figure 2.4.5 Increased expression levels of bone-related genes by cells grown on modular
proteins. Gene expression was measured by qPCR. The relative expression levels of
Runx2, AP, and type I col of cells grown on TCP or the proteins were normalized by
GAPDH (a housekeeping gene) and are reported relative to the control (TCP) at each
time point. Data (n=4-6) are represented as mean ± standard deviation. * indicates p <
0.05 compared to the positive control (TCP) at each time point as assessed by Dunnett‘s
test.
The expression of Runx2 and type I col was enhanced on the RZ-BMP+RZ-RGD
proteins at all time points compared to control (TCP). Furthermore, cells on RZBMP+RZ-RGD had increased AP levels on day 4. Cells on RZ-BMP+RZ-scRGD had
responses similar to those on RZ-BMP+RZ-RGD except that Runx2 levels were not
enhanced on day 4.
We also analyzed OPN and BSP, which are late markers of osteogenic
differentiation, but no differences between groups were observed (Figure 2.8.4). To
confirm whether cell differentiation on proteins is osteogenic-specific, we assessed the
expression level of type II col, which is commonly associated with cartilage matrix. The
type II col levels on all proteins were statistically equivalent at all time points (Figure
2.8.4), suggesting that cells are not undergoing cartilage differentiation.
2.5

Discussion

The full-length BMP-2 growth factor is a potent cue for promoting osteogenic
differentiation and is approved by the Food and Drug Administration (FDA) to be used
clinically to regenerate bone defects [21]. Despite the efficacy of the full-length BMP-2
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growth factor on bone regeneration, its use in clinical applications in soluble form (e.g.,
addition of soluble BMP-2, adsorption or encapsulation of BMP-2 in scaffold materials)
is hampered by several factors. First, the production of recombinant human BMP-2
(rhBMP-2) is not yet cost-effective [81]. Mammalian cells result in low yields of rhBMP2, and rhBMP-2 produced in bacteria (i.e., E. coli) is usually found in inclusion bodies,
which complicates purification due to the additional steps of solubilization and refolding
[82, 83]. Second, the effective clinical concentration of soluble BMP-2 is often supraphysiological (e.g., several milligrams) [84], which causes adverse effects such as softtissue swelling [85] and inflammation [86]. Third, rhBMP-2 has a short half-life and
retention time [71].
An attractive alternative to using soluble full-length BMP-2 growth factor is to
incorporate the short BMP-2 peptide [23], which is known to promote bone regeneration,
into a scaffold material. The shorter length reduces the production cost. Moreover,
attaching the peptide to the material potentially lowers the overall concentration because
of the increased local concentration and because the peptide does not diffuse away from
the target site. This strategy has resulted in enhanced osteogenic differentiation and bone
regeneration in biomaterials that present the BMP-2 peptide through covalent
immobilization [25, 72, 74] or specific binding on the surface of the material [26, 75].
However, none of these studies have explored directly incorporating the BMP-2 peptide
within the material backbone and examined its bioactivity within the context of a
genetically-engineered biomaterial.
Our approach enables multiple functionalities to be incorporated within the
backbone of a single material. Because the amino acid sequence can be tightly controlled
at the molecular level, genetic engineering allows us to precisely engineer materials to
elicit desired cell responses [59]. In addition, given that the bioactive cues are
incorporated into the backbone of the materials, our approach simplifies material
preparation and characterization because it eliminates the additional steps needed to
immobilize the cues on the material and quantify the ligand density.
Our modular proteins supported hMSC proliferation (Figure 2.4.2), and the BMP2 peptide in the modular proteins accelerated osteogenic differentiation compared to the

26
control (TCP) (Figure 2.4.3, Figure 2.4.4, and Figure 2.4.5). When seeded on the RZBMP proteins, hMSCs showed higher levels of AP activity, calcium deposition, and gene
expression of Runx2 and type I collagen compared to cells on TCP. Cells on RZ-BMP
surfaces did not show higher AP gene expression than those on TCP. Given that mRNA
is regulated upstream of protein translation and protein activity and that previous
literature shows that AP expression levels are transient [87, 88], one potential reason for
this discrepancy is that the time points we selected did not capture the transient increase
in AP gene expression on RZ-BMP. In fact, AP enzyme activity on RZ-BMP surfaces
was already elevated at day 4 in our results, and we postulate that AP gene expression on
RZ-BMP may have increased and reached a peak prior to this time point. The pattern of
AP gene expression peaking at an earlier time point than AP enzyme activity has been
previously observed in literature [89]. The surface density of the BMP-2 peptide within
the context of genetically-engineered biomaterials (69 ± 17 pmol/cm2, Figure 2.8.1B) was
similar to the density from previous studies when the peptide was grafted on materials
(5.2-120 pmol/cm2 [25, 27, 90]). The bioactivity of the RZ-BMP proteins is likely to be
osteogenic-specific, as there was no increase in the expression level of a cartilage marker
(type II col) at all time points (Figure 2.8.4). Moreover, we confirmed that the bioactivity
of the RZ-BMP proteins did not result from proteins desorbed from the plate (Figure
2.8.3). Thus, these results demonstrate the bioactivity of the BMP-2 peptide within the
context of our modular proteins and the potential of our genetically-engineered
biomaterials for accelerating osteogenic-specific differentiation.
The RZ-scBMP proteins, which serve as sequence-scrambled negative control
proteins, increased a couple of osteogenic markers. Specifically, calcium deposition at
day 11 and gene expression of type I collagen on day 7 were increased compared to TCP.
We hypothesize that these effects may be due to the higher protein density of RZ-scBMP
compared to other proteins (Figure 2.8.1B). In fact, several experiments which sought to
use the same density of RZ-BMP and RZ-scBMP confirmed that the only the RZ-BMP
and not the RZ-scBMP surfaces promote increased calcium deposition compared to TCP
(Figure 2.8.5). Another possibility is that Alizarin red S staining is a rather unspecific
measurement of osteogenic differentiation. In any case, when compared to the cell
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response on RZ-BMP proteins, cells on RZ-scBMP proteins did not enhance as many
osteogenic markers. From these results, we conclude that the authentic BMP-2 peptide
sequence elicits a more robust response compared to the scrambled sequence. Thus, the
cells appear to respond to the RZ-BMP proteins in a sequence-specific manner.
Interestingly, it appeared that the RZ-BMP+RZ-scRGD proteins induced
osteogenic differentiation similar to that of the RZ-BMP proteins. Specifically, the AP
activity and calcium deposition were statistically equivalent between the two groups
(Figure 2.4.3 and Figure 2.4.4, p < 0.05, Tukey’s post hoc test). In addition, the RZBMP+RZ-scRGD proteins upregulated more osteogenic genes than the RZ-BMP proteins
did. In particular, the RZ-BMP+RZ-scRGD surfaces upregulated the gene expression of
Runx2 (day 7), AP (day 4), and type I col (day 4) (Figure 2.4.5), whereas the RZ-BMP
proteins did not. Overall, it appeared that the RZ-BMP and RZ-BMP+RZ-scRGD
proteins both resulted in enhanced osteogenic differentiation compared to TCP.
We note that the density of the BMP-2 peptide was significantly lower on the RZBMP+RZ-scRGD surface than the RZ-BMP surface. In particular, the total amount of
proteins was approximately equal on the RZ-BMP and RZ-BMP+RZ-scRGD surfaces
(Figure 2.8.1B). But, because the RZ-BMP+RZ-scRGD protein surface is a 50:50
mixture, the BMP-2 peptide density on the RZ-BMP+RZ-scRGD surfaces is ~33
pmol/cm2, which is almost half the density on the RZ-BMP proteins (69 pmol/cm2).
Taken together, these results suggest that peptide densities of 33-69 pmol/cm2 are
sufficient to promote osteogenic differentiation and that, within this range, the density of
the bioactive ligand (i.e., the BMP-2 peptide sequence) did not significantly influence the
extent of osteogenic differentiation. As a comparison, full-length BMP-2 growth factor
immobilized on biomaterials promotes osteogenic differentiation at a density of 1.15-15.4
pmol/cm2 [91, 92], which are lower than the density of the BMP-2 peptide in our study.
In our study, a combination of the BMP-2 peptide and RGD did not display
synergistic effects on differentiation. In fact, it appeared as if the RZ-BMP+RZ-RGD
surfaces were less potent than either the RZ-BMP or RZ-BMP+RZ-scRGD surfaces in
promoting osteogenic differentiation. Although the RZ-BMP+RZ-RGD surfaces did
increase osteogenic gene expression (Figure 2.4.5), the increased gene expression did not
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translate into higher AP activity or calcium deposition compared to TCP (Figure 2.4.3
and Figure 2.4.4). To verify these results, we confirmed that the amino acid sequences of
the bioactive domains in the RZ-RGD and RZ-scRGD proteins were correct by analyzing
both proteins through peptide sequencing (see Materials and Methods 2.3).
Previous studies report conflicting results as to whether the BMP-2 peptide and
the RGD cell-binding domain have a synergistic effect on osteogenic differentiation [25,
27, 28, 93]. Some studies reported that when the RGD and BMP-2 peptides were grafted
onto materials, higher osteogenic differentiation was observed compared to materials
containing only the BMP-2 peptide [25, 28]. Moore et al. investigated the effect of
concentration of both peptides on osteogenic differentiation and reported the synergistic
enhancement on BSP expression only at a total concentration of 130 pmol/cm2 (i.e., 65
pmol/cm2 for each peptide) [27]. However, Koepsel et al. observed that the RGD and
BMP-2 peptides did not have a significant effect on AP activity [93]. Potential reasons
for the conflicting results regarding synergy could be due to differing peptide densities or
modes of ligand presentation within the studies.
Last, given that the RZ-BMP+RZ-scRGD surface promoted osteogenic
differentiation but the RZ-BMP+RZ-RGD surface did not, it appeared as if the presence
of the RGD cell-binding domain suppressed the protein expression and calcium
deposition elicited by the BMP-2 peptide sequence. There are several potential reasons
that may contribute to this result. First, the RGD domain in the RZ-BMP+RZ-RGD
surfaces may delay osteogenic differentiation due to strong cell adhesion to the surfaces.
Previous studies demonstrate that RGD-modified materials resulted in a slower rate of
osteogenesis than unmodified ones [94, 95]. Second, when cells are cultured on the RZBMP+RZ-RGD surfaces, the enhanced osteogenic differentiation elicited by the BMP-2
peptide could be suppressed by integrin binding to the RGD domain. The RGD sequence,
which is derived from fibronectin, interacts primarily with the αvβ3 and α5β1 integrins [96,
97], which are expressed on the membrane of hMSCs [98, 99] and human osteoblast-like
cells [100]. In our study, it is likely that only the αvβ3 integrins bind the RGD domain in
RZ-RGD because α5β1 binding requires both the RGD sequence and the PHSRN synergy
site found in fibronectin [101]. There are conflicting reports as to whether the αvβ3
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integrins promote or suppress osteogenic differentiation [102-107]. However, some
studies have observed that osteogenic differentiation was suppressed by αvβ3 integrin
binding, and the inhibition was rescued by blocking the αvβ3 integrins [103, 105]. In
addition, RGD-functionalized surfaces that support αvβ3 binding retarded osteogenic
differentiation [106]. Thus, it is possible that αvβ3 integrin binding to the RGD domain in
RZ-RGD resulted in inhibition of osteogenic differentiation elicited by the BMP-2
peptide in RZ-BMP. However, further investigation is needed to identify the mechanism
that contributes to the cell response observed on the RZ-BMP+RZ-RGD surface.
Taken together, our results demonstrate that the modular protein design provides a
new strategy for incorporating the BMP-2 peptide in materials. We found that the BMP-2
peptide in modular proteins accelerated osteogenic differentiation of hMSCs and induced
robust osteogenic differentiation in a sequence-specific manner.
2.6

Conclusions

This work successfully demonstrated a new strategy to incorporate the BMP-2
peptide in biomaterials for applications in bone tissue engineering. By using genetic
engineering, a strategy that allows us to precisely control material properties, we
incorporated the BMP-2 peptide into the backbone of our protein-based biomaterials. We
found that, within the context of our modular proteins, the BMP-2 peptide was bioactive
and accelerated osteogenic differentiation in a sequence-specific manner. In addition, our
results showed that the density of the BMP-2 peptide (i.e., 33 pmol/cm2 on RZBMP+RZ-scRGD or 69 pmol/cm2 on RZ-BMP) did not affect the extent of cell
differentiation. Within the context of our modular proteins, the BMP-2 peptide did not
synergize with the RGD cell-binding sequence. Overall, our results suggest that
incorporation of bioactive peptides (the BMP-2 peptide in this study) into geneticallyengineered proteins is a promising strategy for developing biomaterials for bone tissue
engineering.
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Supporting Information

Circular Dichroism (CD):
Protein solutions (0.2 mg/mL in Milli-Q water) were scanned on a Jasco-815
Circular Dichroism spectrometer at room temperature using a 0.1 cm path length. The
spectrum is an average of three scans.
Surface Quantification:
The density of proteins adsorbed on TCP was quantified by using the QuantiPro
BCA assay kit. Briefly, 50 µL of PBS was added to the protein surface and mixed with an
equal amount of the reagent. After incubation for 1 h at 60 °C, the absorbance at 562 nm
was measured. A standard curve was created using the individual proteins in PBS. Five or
six replicates per group were examined.
Cell Culture:
To investigate the effect of proteins that may be desorbed from the plate, cells
were seeded on TCP and cultured in pre-conditioned medium. First, RZ-BMP proteins
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were adsorbed on TCP as described in the main text. Next, medium (low-glucose
Dulbecco’s modified Eagle’s medium (DMEM) containing 100 U/mL penicillin and 100
mg/mL streptomycin (Invitrogen)) was incubated on either TCP or RZ-BMP surfaces for
three days at 37 °C and 5% CO2. The medium was then supplemented with 10% fetal
bovine serum (Lonza), 100 nM dexamethasone, 50 µM ascorbic acid 2-phosphate, and 10
mM glycerol-2-phosphate disodium salt hydrate. The osteogenic pre-conditioned medium
was added to cells grown on TCP after they reached a confluence of 70-85%. The preconditioned medium was replaced every three days.
Statistical Analysis:
All data are represented as mean ± standard deviation. All data passed normality testing
by Shapiro-Wilk test and homogeneity of variance by Levene’s modified test. A one-way
(Figure 2.8.1B and Figure 2.8.4) or two-way (Figure 2.8.1A) analysis of variance
(ANOVA) was performed. To determine significant differences between groups, a
Tukey’s post hoc test (Figure 2.8.1), a two-tailed t-test (Figure 2.8.3), or Dunnett’s test
was performed. All statistical analyses were performed using Statistical Analysis
Software (SAS, version 9.2), and a p-value less than 0.05 was considered statistically
significant.
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Table 2.8.1 Primer sequences for quantitative reverse transcription-polymerase chain
reaction
Gene

Accession number

Primer sequence (5‘ → 3‘)

Efficiency

Product

Reference

length
(bp)
Runx2

NM004348.3

F
R

AP

NM00478.4

F
R

Type I col

NM000088

F
R

OPN

NM001040060.1

F
R

BSP

NM004967

F
R

Type II col

NM001844.4

F
R

GAPDH

NM002046.3

F
R

CTTCAAGGTGGTAGCC
CTCGGAGAG
AACAGCAGAGGCATTC
CGGAGC
GTACTGGCGAGACCAA
GCGCAA
CACCCATCCCATCTCC
CAGGAACA
TCTGACTGGAAGAGTG
GAGAGTACTGG
ACCAGTTCTTCTGGGC
CACACT
GTGGGAAGGACAGTTA
TGAAACG
CTGACTATCAATCACA
TCGGAAT
GGGCAGTAGTGACTCA
TCCGAAG
CTCCATAGCCCAGTGT
TGTAGCAG
GGCAATAGCAGGTTCA
CGTACA
CGATAACAGTCTTGCC
CCACTT
ACAGTCAGCCGCATCT
TCTT
TTGACTCCGACCTTCA
CCTT

97%

106

Designed

96%

110

Designed

102%

139

[79]

96%

134

[108]

96%

164

[109]

96%

79

[110]

102%

81

[111]
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Table 2.8.2 Amino acid analysis of RZ-BMP and RZ-scBMP proteins

ASX
SER
GLX
GLY
HIS
ARG
THR
ALA
PRO
TYR
VAL
MET
LYS
ILE
LEU
PHE
Total

RZ-BMP
Observed
mol%
4.00
13.36
13.68
8.43
4.48
2.32
7.62
13.62
11.87
0.66
1.28
2.74
5.07
1.55
3.70
5.62
100.00

RZ-scBMP
Observed
mol%
3.67
13.95
13.71
8.40
4.81
2.10
7.68
13.48
12.37
0.63
0.83
3.00
5.05
1.16
3.40
5.77
100.00

Calculated
mol%
3.37
14.61
13.48
8.43
5.06
1.69
7.87
13.48
12.36
0.56
0.56
3.37
5.06
1.12
3.37
5.62
100.00
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Figure 2.8.1 Adsorbed protein density. (A) Adsorption isotherms show the adsorbed
protein density as a function of concentrations of the protein solutions. A two-way
ANOVA was used to determine whether protein identity or concentration had a
significant effect on adsorbed protein density. The protein identity did not affect adsorbed
protein density, whereas the concentration did. The adsorbed protein density increased at
a concentration of 0.5 mg/mL and saturated at a concentration of 1 mg/mL. Therefore, in
this work, we chose a protein concentration of 1 mg/mL to prepare our surfaces. Data
(n=3-5) are represented as the mean ± standard deviation. (B) For the cell differentiation
studies shown in Figure 2.4.3, Figure 2.4.4, and Figure 2.4.5, the density of the adsorbed
protein surfaces was quantified. A one-way ANOVA and Tukey‘s post hoc test were
performed, and different letters denote significant differences (p < 0.05) between groups.
The RZ-BMP, RZ-BMP+RZ-scRGD, and RZ-BMP+RZ-RGD surfaces had statistically
equivalent protein densities, whereas the RZ-scBMP surface had a 1.6-fold higher protein
density compared to the other surfaces. Data (n=6) are represented as mean ± standard
deviation.
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Figure 2.8.2 The secondary structure of modular proteins evaluated by CD spectroscopy.
The results demonstrated that the RZ-BMP and RZ-scBMP proteins have an unordered
structure. CD spectra were measured using protein solutions at 0.2 mg/mL in Milli-Q
water at room temperature.
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Figure 2.8.3 The effect of protein desorption on osteogenic differentiation. Human MSCs
on TCP were cultured in pre-conditioned medium that had been incubated on TCP (preTCP) or on RZ-BMP protein surfaces (pre-RZ-BMP). Cells were stained with Alizarin
red S and the amount of dye was quantified. Compared to cells cultured in pre-TCP
medium, cells cultured in pre-RZ-BMP medium did not show an increase in calcium
deposition. These results demonstrate that RZ-BMP protein desorption did not contribute
to the results observed in Figure 2.4.2, Figure 2.4.3, Figure 2.4.4, and Figure 2.4.5. The
error bars indicate the standard deviation of six replicates. A two-tailed t-test was
performed to determine statistical difference between two groups. * represents p < 0.05
compared to pre-RZ-BMP at the same time point.
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Figure 2.8.4 Relative mRNA expression levels of osteopontin (OPN), bone sialoprotein
(BSP), and type II collagen (type II col) measured by qPCR. Expression levels were
normalized by GAPDH (a housekeeping gene) and are reported relative to the control
(TCP) at each time point. Data (n=4-6) are represented as mean ± standard deviation.
Dunnett‘s test indicated that, at all time points, there were no statistical differences
between each group and the control (TCP).
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Figure 2.8.5 Accelerated calcium deposition on RZ-BMP surfaces. Cells were stained
with Alizarin red S at three time points during osteogenic differentiation, and the amount
of dye was quantified. At 11 and 13 days, cells grown on the RZ-BMP surfaces exhibited
statistically higher calcium deposition than cells on TCP. * denotes p < 0.05 compared to
the positive control (TCP) at that time point as determined by Dunnett‘s test.
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CHAPTER 3. PROTEIN-ENGINEERED MICROENVIRONMENTS CAN PROMOTE
ENDOTHELIAL DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS
IN THE ABSENCE OF EXOGENOUS GROWTH FACTORS

This chapter consists of a manuscript by Kim Y and Liu JC, prepared for submission in
2014.

3.1

Abstract

Peripheral artery disease often requires treatments with vascular grafts for vessel
reconstruction. Endothelialization of the vascular grafts is important to achieve long-term
patency because endothelial cells regulate thrombosis, inflammation, and growth of
smooth muscle cells. One potential source of endothelial cells is human mesenchymal
stem cells (hMSCs), which can be routinely differentiated towards the endothelial lineage
using exogenous growth factors such as VEGF. However, there are few studies that
investigate the effect of materials on endothelial differentiation in the absence of growth
factors. This study demonstrates that exogenous growth factors are not needed to achieve
endothelial differentiation of hMSCs and that protein-based microenvironments promote
endothelial differentiation. Cells grown on the protein-engineered microenvironments
were viable, had normal metabolic activity, and displayed increased endothelial-specific
markers and endothelial function. In particular, cells cultured on our proteins formed
networks that were statistically equivalent to positive control cells. We confirmed that
enhanced endothelial differentiation on our proteins is protein-specific, as a noninteractive protein did not show similar enhancements. Thus, our protein-based materials
are promising tools for obtaining endothelial cells for use in vascular grafts.
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3.2

Introduction

Peripheral artery disease is caused by excessive deposition of plaques on the inner
surface of an artery. Approximately 8.5 million Americans currently suffer from the
disease, and by 2050, the projected number of patients is expected to be 19 million [89].
To treat the disease, a surgical bypass or vessel replacement is often required if the vessel
is severely blocked with plaques. Replacement with autologous artery or vein from the
patient‘s body is the current gold standard for treatment. However, the availability of
donor vessels may be limited due to vascular disease or previous harvest. Synthetic graft
materials

such

as

poly(ethylene

terephthalate)

(PET)

or

expanded

poly(tetrafluoroethylene) (ePTFE) are widely employed alternatives [12], but their
performance is unsatisfactory in small-diameter vessels (i.e., less than 6 mm) such as
peripheral arteries. After five years, the grafts showed poor performance and a low
patency rate (i.e., 30 %) due to thrombosis and intimal hyperplasia [112-115]. These
failures resulted from the absence of a confluent endothelial cell layer on the interior of
the graft and a mismatch in mechanical properties between the graft and surrounding
tissue.
The lack of endothelium remains one of the major challenges in achieving a high
patency rate in small-diameter vascular grafts. Because endothelial cells regulate
inflammation, thrombosis, and growth of smooth muscle cells, one approach has been to
increase patency rates by pre-seeding endothelial cells on small-diameter vascular grafts.
One clinical study demonstrated that ePTFE grafts seeded with autologous endothelial
cells resulted in significantly higher patency rates of 85 and 65% after 3 and 7 years,
respectively, compared to non-endothelialized grafts with rates of 50 and 16% [116].
Another study found that grafts seeded with endothelial-like cells, which were obtained
by differentiating mesenchymal stem cells, had increased patency and tissue regeneration
in a canine model compared to grafts prepared without cell seeding [117].
Cell source is an important consideration when designing strategies to establish an
endothelial layer on vascular grafts. Autologous endothelial cells already have the desired
functional characteristics and avoid immunogenicity issues. However, autologous
endothelial cells often exhibit dysfunction when patients have vascular diseases [114]. As
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an alternative, bone marrow mesenchymal stem cells (MSCs) have emerged as an
attractive source because they have a high proliferation capacity and can be differentiated
into endothelial-like cells. Also, aspiration of MSCs from bone marrow is less invasive
compared to blood vessel biopsies, which are used to obtain mature endothelial cells.
Endothelial differentiation of MSCs has been achieved by several different
methods. For example, vascular endothelial growth factor (VEGF) has been routinely
added to culture medium [6, 118, 119] or immobilized on biomaterials [120] to promote
endothelial differentiation in vitro. Another study reported that a combination of chemical
(i.e., VEGF) and mechanical stimulation (i.e., shear stress) enhanced endothelial marker
expression of MSCs [121]. Culture conditions such as serum deprivation in medium [7]
and high cell plating density [8] induced endothelial differentiation of MSCs.
D‘Andrea and coworkers synthesized a short VEGF-mimicking peptide, referred
to as QK, which mimics full-length VEGF function by binding VEGF receptors [24].
Soluble QK promoted endothelial cell proliferation and capillary formation in vitro [24]
and accelerated would healing in vivo [122]. The QK peptide is also bioactive when
incorporated into biomaterials as a material-based cue, as QK-incorporated materials
have shown enhanced endothelial cell proliferation and function [29-33]. One advantage
of this method is that the bioactivity of the incorporated QK peptide can be retained
longer than the bioactivity of the soluble peptide. However, none of the studies examined
whether QK-containing materials affect endothelial differentiation of stem cells.
To our knowledge, there have been few studies showing that engineered
biomaterials can promote endothelial differentiation of human MSCs (hMSCs) in the
absence of exogenous growth factors [120]. In this study, we engineered biomaterials to
induce cell differentiation towards the endothelial lineage. The biomaterials, hereafter
referred to as the RZ-QK protein, were manufactured by genetic engineering to include
two different domains, a resilin structural domain (RZ) and the QK peptide domain
(Figure 3.2.1A). We included a resilin-like sequence derived from mosquito to provide
structural integrity, and its elastic properties [123] potentially allow us to apply our
materials in a three-dimensional system for vascular engineering. Our previous work
showed that similar materials were cytocompatible [57, 124]. The QK peptide, which
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mimics VEGF function, was incorporated into the backbone of the material. The goal of
this study was to determine if our engineered proteins could serve as microenvironments
that enable hMSCs to survive, proliferate, and differentiate towards the endothelial
lineage. First, we produced and characterized the protein and assessed the viability and
metabolic activity of hMSCs on our protein. Next, we investigated whether proteinengineered microenvironments can induce endothelial differentiation of hMSCs in the
absence of VEGF by evaluating endothelial marker expression and function.

Figure 3.2.1 The protein (RZ-QK) in this study is pure and has unstructured secondary
structure. (A) The full amino acid sequence of the protein is shown. The protein contains
a resilin-like sequence (RZ) and a peptide (QK) derived from VEGF. On the N-terminus,
the protein has a T7 tag for protein identification, a heptahistidine tag (His tag) for
protein identification or purification, and an enterokinase cleavage site for tag removal.
(B) Protein expression and purification were confirmed by SDS-PAGE. The RZ-QK
protein band appeared between the 17 and 23 kDa of marker proteins as the expected
molecular weight is 18.7 kDa. The protein was successfully expressed by IPTG induction
(lane 2) and was pure (>98.5% assessed by densitometry analysis, lane 3) after
purification. (C) CD spectroscopy of the RZ-QK protein showed an unordered secondary
structure. CD spectra were obtained using protein solutions at 0.2 mg/mL in Milli-Q
water at room temperature.
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3.3

Materials and Methods

Materials and Reagents:
All materials and reagents used in this study were purchased from Sigma-Aldrich
unless stated otherwise.
Material Design:
The recombinant DNA encoding the RZ-QK protein sequence was manufactured
using the methods previously described [77]. In this study, the protein consisted of ten
repeats of a resilin-like sequence (RZ) derived from Anopheles gambiae and the QK
peptide derived from vascular endothelial growth factor (VEGF) [24]. The protein
sequence is shown in Figure 3.2.1A.
Protein Expression and Purification:
Protein expression and purification were performed as previously described [57].
Briefly, proteins were expressed in a 14 L fermentor (BioFlo 110, New Brunswick), and
the expression was induced by isopropyl β-D-1-thiogalactopyranoside (IPTG, Denville
Scientific). Following expression, proteins were purified by a combination of salting-out
and heating methods. Briefly, undesired proteins were precipitated by adding 10%
ammonium sulfate to the lysed cell solution, and the desired proteins were then
precipitated by adding the same amount of ammonium sulfate as the one in the previous
step. Thus, the final concentration of ammonium sulfate that had been added to the initial
cell solution was 20%. Next, undesired proteins were removed by heating the sample at
75-80 ˚C for 10 min. Protein purity was confirmed by using sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) analysis followed by densitometry
analysis of the gel using ImageJ software (National Institutes of Health, NIH). The
molecular

weight

of

the

protein

was

evaluated

by

matrix-assisted

laser

desorption/ionization time-of-flight (MADLI-TOF) mass spectroscopy. The composition
of proteins was assessed by amino acid analysis (Purdue Proteomics Facility at the
Bindley Bioscience Center).
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Circular Dichroism (CD):
The secondary structure of the protein was assessed by circular dichroism. Protein
was dissolved in Milli-Q water at 0.2 mg/mL before loading in a Jasco-815 Circular
Dichroism spectrometer. The measurement was performed at room temperature using a
0.1 cm path length. Three scans were averaged to show spectrum data.
Surface Preparation and Quantification:
Proteins were adsorbed onto surfaces, and the density of the proteins that had
been adsorbed on tissue culture polystyrene (TCP) was assessed by the QuantiPro BCA
assay as previously described [124]. In this study, the density of the RZ-QK protein
ranged from 3.5 – 4.0 µg/cm2 unless stated otherwise.
Cell Culture:
In all experiments, hMSCs (Lonza, PT-2501) were incubated in a humid
environment at 37 °C with 5% CO2. For sub-culturing, cells were cultured in
maintenance medium consisting of low-glucose Dulbecco‘s modified Eagle‘s medium
(DMEM) supplemented with 10% fetal bovine serum (Lonza, 18-501F), 100 U/mL
penicillin, and 100 µg/mL streptomycin (Invitrogen, 15140-122). Cells were seeded at a
density of 5,000-6,000 cells/cm2 and were sub-cultured using 0.05% Trypsin-EDTA
(Gibco, 25300-054) after they reached 60-80% confluence.
To investigate cell responses to the protein, hMSCs were seeded on TCP or
protein surfaces in maintenance medium at a density of 6,250 cells/cm2 and grown for 2
days until they reached 70-80% confluence, at which point differentiation was initiated
by introducing a differentiation medium. There have been several medium compositions
reported and used for endothelial differentiation of MSCs [6, 7, 125]. We screened
medium compositions based on literature (data not shown) and chose two different media
as stated below.
To start differentiation towards the endothelial lineage, the maintenance medium
was switched to either one of two media depending on the group. For the negative control
(i.e., cells on TCP) and cells cultured on proteins, basal differentiation medium (BDM)
was used. The composition of BDM was similar to that of maintenance medium except
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that 10% fetal bovine serum (Lonza, 18-501F) was replaced by 5% fetal bovine serum
(Atlanta Biologics, S11550). The positive control was differentiated on TCP in positive
differentiation medium (PDM) consisting of endothelial cell growth medium-2 (Lonza,
cc-3162) supplemented with an additional 50 ng/mL VEGF (R&D Systems, courtesy of
the National Cancer Institute Preclinical Repository). The total VEGF concentration in
PDM was 52 ng/mL. To eliminate the effect of lot-to-lot variability on cell responses,
both media contained serum from the same lot. The medium was replaced every other
day. All experiments were performed using cells at passage 4 to reduce the effect of cell
senescence on differentiation, and cells were obtained from the same donor to eliminate
donor-to-donor variability [126]. For all of the differentiation assays, the medium was
replaced 24 h prior to the assay to prevent serum starvation.
Live/Dead Cytotoxicity Assay:
Cell viability on protein surfaces was evaluated using a LIVE/DEAD kit
(Molecular Probes, L3224). At 2 days of seeding, cells were washed with phosphatebuffered saline (PBS) supplemented with 0.90 mM calcium chloride and 0.49 mM
magnesium chloride (Ca/Mg-PBS). Then, cells were incubated in Ca/Mg-PBS containing
0.5 µM calcein AM and 0.75 µM ethidium homodimer-1 for 35 min at 37°C. Cells were
rinsed with Ca/Mg-PBS and imaged using a 4x objective on a Nikon Ti-E microscope. A
fluorescein isothiocyanate (FITC) and a tetramethyl rhodamine isothiocyanate (TRITC)
filter cube were used to image calcein AM and ethidium homodimer-1, respectively. Live
and dead cells were analyzed using NIS-Elements software. To ensure that dead cells
were detected by the dye solutions at the concentrations used, negative control cells were
treated with 70 (v/v) % ethanol for 30 min prior to incubation with the dyes. As a positive
control, cells were cultured on adsorbed gelatin. The gelatin surfaces were prepared by
incubating solutions of 1 (w/v) % gelatin in Milli-Q water on each cover glass for 10 min
at room temperature. The gelatin surfaces were dried for 30 min before cell seeding. Cell
viability was quantified by analyzing images from each group, which had at least 250
cells per replicate (n=4).
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Cellular Metabolic Activity:
Cellular metabolic activity was assessed by using the CytoScan WST-1 cell
proliferation assay (G Biosciences, 786212). Briefly, the reagent was added at a ratio of
1:10 to each well containing either BDM or PDM. Following incubation for 4 h at 37 °C,
the absorbance of the medium was measured with a SpectraMax M2e (Molecular
Devices). At each time point, metabolic activity was determined as the percentage
relative to the negative control for differentiation (i.e., cells on TCP differentiated in
BDM). Five replicates per group were examined.
Acetylated-Low Density Lipoprotein (ac-LDL) Uptake:
At each time point, cells were trypsinized and reseeded at a density of 10,000
cells/cm2 on acid-cleaned cover glasses. Cells that had been differentiated in BDM and
PDM were reseeded in BDM and PDM without additional VEGF, respectively. After 4 h
of seeding, cells were incubated for another 4 h in either BDM for the negative control
and RZ-QK groups or PDM without additional VEGF for the positive control. All of the
media contained acetylated-LDL tagged with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (Dil-ac-LDL) (Alfa Aesar, BT-902) at a final concentration
of 2 µg/mL. Then, cells were fixed with 4 (w/v) % formaldehyde in PBS and washed
with PBS three times. Cover glasses were mounted on microscope slides and stored in the
dark at 4 °C until imaging.
All images were taken using a Nikon Ti-E with a differential interference contrast
(DIC) 20x objective. The uptake of Dil-ac-LDL was imaged using a TRITC filter cube.
Cells positive for Dil-ac-LDL uptake were chosen by setting threshold levels at which no
fluorescence was observed in the proliferating group. The total number of cells per image
was counted using the DIC images, and the percentage of cells positive for Dil-ac-LDL
was determined. Five replicates per group were examined and at least 100 cells per
replicate were counted.
In vitro Angiogenesis Assay:
Angiogenic response was evaluated by an in vitro angiogenesis kit (Millipore,
ECM 625). According to the manufacturer‘s instructions, 50 µL of gel solution mixture
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was pipetted into individual wells of a 96-well plate and incubated for 2 h at 37 °C. Cells,
which had been cultured on each surface in BDM or PDM for 12 days, were reseeded on
the gel at 70,000 cells per well. After 6 h of incubation, cells were imaged on a Nikon TiE microscope using a 4x objective. Five replicates per group were evaluated. For
quantification, total network length per area, the number of branching points per area, and
the number of polygons per area were evaluated using the Nikon NIS-Elements AR
software.
Quantitative Reverse Transcription–Polymerase Chain Reaction (qPCR):
Samples were processed and analyzed as previously described [124] unless
otherwise stated. The complementary DNA (cDNA) was synthesized by using at least 0.7
µg purified RNA. For qPCR, all individual samples were run in duplicate. The primer
sequences for vascular endothelial-cadherin (VE-cad), platelet endothelial cell adhesion
molecule (PECAM), Ephrin-B1, Ephrin-B2, EphB4, chicken ovalbumin upstream
promoter-transcription

factor

II

(COUP-TFII)

and

glyceraldehyde-3-phosphate

dehydrogenase (GAPDH) were obtained from references or designed using Primer-Blast
on the NIH website (Table 3.8.1). Primer efficiencies were obtained by using serial
dilutions of cDNA from either human umbilical vein endothelial cells or human aortic
endothelial cells. During the PCR reaction, the annealing temperature was 60 ˚C except
for Ephrin-B1 and Ephrin-B2, which had an annealing temperature of 64 ˚C. The relative
gene expression level was calculated by the ∆∆ Ct method; GAPDH was used as the
housekeeping gene, and expression levels were determined relative to proliferating cells
at day 0. Three to five replicates per group were examined.
Immunofluorescence:
Cells were reseeded on cover glasses as those for the ac-LDL uptake assay. After
4 h of incubation, cells were washed with PBS twice, fixed with 4 (w/v) % formaldehyde
in PBS at room temperature for 25 min, and washed with PBS three times. Cells were
permeabilized with 0.1 (v/v) % Triton X-100 in PBS for 25 min and rinsed with PBS
three times. Cells were blocked with 10 (w/v) % bovine serum albumin (BSA) in PBS for
1 h at room temperature to prevent nonspecific binding. Then, cells were incubated with a
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primary antibody specific for von Willebrand factor (vWF) (Santa Cruz Biotechnology,
sc-53666) (diluted at a ratio of 1:50 in a 10% BSA solution) at room temperature for 1 h.
Cells were washed with PBS three times and incubated for 1 h at room temperature with
Alexa Fluor 488-tagged secondary antibody (Life Technologies, A11001), which was
diluted in a 10% BSA solution at a ratio of 1:2,000. To ensure specificity of the
secondary antibody for the primary antibody, a couple of replicates were incubated in the
BSA solution without primary antibody and served as a no primary antibody control
group. After washing with PBS three times, nuclei were stained for 20 min at room
temperature with DRAQ5 (Biostatus, DR50200) diluted 1:500 in PBS. Cover glasses
were mounted on microscope slides using a mounting medium of 50 (v/v) % glycerol in
PBS and stored in the dark at 4 °C until imaging.
All images were obtained on the same day with identical laser intensity and PMT
gain settings by using a 20x objective on a Nikon Ti-EC-1 Plus microscope. Three or four
replicates of each group were examined. A population of at least 80 cells per replicate
was imaged. To analyze fluorescence images, Nikon NIS-Elements AR software (version
3.2) was utilized. Individual cells were chosen as regions of interest (ROI) by setting
threshold levels at which no fluorescence was observed in the no primary antibody
control group. For quantification, the mean pixel intensity per cell from three replicates
was pooled to show the percentage of the population expressing vWF.
Statistical Analysis:
All data are represented as mean ± standard deviation. Normality and
homogeneity of variance were confirmed by Shapiro-Wilk and Levene‘s modified tests,
respectively. A one-way analysis of variance (ANOVA) was performed to determine
whether significant differences among groups existed. Statistical differences between the
proliferating group at day 0 and an experimental group at day 12 were examined by
Dunnett‘s test. Tukey‘s post hoc test was used to determine significant differences
between experimental groups. All statistical analyses were conducted by using Statistical
Analysis Software (SAS, version 9.2), and p-values < 0.05 were considered to be
statistically significant.
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3.4

Results

Material Design, Production, and Characterization:
The full amino acid sequence of the protein is shown in Figure 3.2.1A. The RZQK protein consists of a resilin domain (RZ) and QK domain (QK), which is included to
promote endothelial differentiation of hMSCs. The recombinant DNA construct encoding
the RZ-QK amino acid sequence was cloned as previously described [77]. The RZ-QK
protein was successfully expressed by IPTG induction and purified, and the yield of
purified protein was 13.8 mg per liter of culture. On an SDS-PAGE gel, the RZ-QK
protein appeared between the 17 and 23 kDa of protein markers as the expected
molecular weight is 18.7 kDa (Figure 3.2.1B). MALDI-TOF mass spectroscopy
confirmed the molecular weight of the protein as the measured molecular weight was
within 29 Da (0.15 %) of the expected molecular weight (Figure 3.8.1). The purity of the
protein was 98.5% as assessed by densitometry analysis (Figure 3.2.1B). The
composition of the RZ-QK protein was examined by amino acid analysis, which found
that the each component was within 0.6 mol % of the calculated value (Table 3.8.2). CD
spectroscopy revealed that the RZ-QK protein has an unordered structure (Figure 3.2.1C),
which is similar to other resilin-based proteins that were previously reported [57, 124].
Viability and Metabolic Activity of Cells on Proteins:
The viability and metabolic activity of hMSCs grown on the RZ-QK protein were
evaluated by LIVE/DEAD and WST-1 assays, respectively (Figure 3.4.1). First, the
viability of cells grown on the protein surfaces was 99.4 ± 0.3% at day 0 of
differentiation (Figure 3.4.1A) and was statistically equivalent to that on gelatin (positive
control surface for viability, 99.8 ± 0.3%). This result implies that the RZ-QK protein is
cytocompatible.
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Figure 3.4.1 Viability and metabolic activity of human MSCs on the RZ-QK protein. (A)
Cells were grown on gelatin (positive control surface) or on the RZ-QK surface, and cell
viability was measured at day 0 of differentiation. Images of LIVE/DEAD assay are
shown (top). Live cells are green, and dead cells are red. Scale bar represents 250 µm.
Cells had a viability of 99.8 and 99.4 % on gelatin and the RZ-QK surfaces, respectively
(bottom). One-way ANOVA determined that there was no difference in cell viability
between the two surfaces. Data are represented as the average ± standard deviation of
four replicates. (B) Cellular metabolic activity on the RZ-QK protein was measured by
the WST-1 assay, and the results are presented relative to the negative control for
differentiation (i.e., cells grown on TCP in BDM). The negative control and RZ-QK
groups had statistically equivalent metabolic activity at two time points. The positive
control for differentiation (i.e., cells on TCP differentiated in PDM) showed higher
metabolic activity than the negative control and RZ-QK groups due to the presence of
growth factors in PDM. Data are represented as the average ± standard deviation of five
replicates. * indicates a statistical difference (p < 0.05) compared to other two groups at
each time point as assessed by Tukey‘s post hoc test.
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Second, cellular metabolic activity on the RZ-QK protein was measured. Before
starting differentiation at day 0, cells on TCP and the protein were evaluated in the
maintenance medium, and there was no difference in metabolic activity between the two
surfaces (data not shown). For later time points at 4 and 7 days of differentiation, the two
control groups were examined and compared to the RZ-QK group. Cells cultured on TCP
in BDM and PDM served as negative and positive controls for differentiation,
respectively (see details in Cell Culture of section 3.3). The cellular metabolic activity on
the RZ-QK protein did not statistically differ from the negative control at the two time
points (Figure 3.4.1B). The positive control cells showed higher metabolic activity than
the negative control and RZ-QK groups. This difference is because PDM used for the
positive control included growth factor supplements and VEGF, both of which could lead
to increased cell proliferation, whereas BDM used for the negative control and RZ-QK
groups did not contain any growth factors.
RZ-QK Promoted Endothelial Function:
The functional behavior of differentiated cells on the RZ-QK protein was
determined after 12 days of differentiation by ac-LDL uptake (Figure 3.4.2) and in vitro
angiogenesis assays (Figure 3.4.3), respectively. First, the percentage of cells positive for
internalized ac-LDL was quantified (Figure 3.4.2B). For the proliferating group at day 0,
only 2.8% of cells internalized ac-LDL. In contrast, after 12 days, the percentage of cells
positive for ac-LDL was 37.2% on the RZ-QK protein and 66.1% for the positive control.
The ac-LDL internalization by cells on the RZ-QK protein was statistically higher than
that of the proliferating group at day 0 and the negative control at day 12 (21.5%).
The ability to form networks was determined by reseeding differentiated cells on
ECMatrix after 12 days of differentiation (Figure 3.4.3). Cells differentiated on RZ-QK
showed significantly higher total network length, number of branching points, and
number of polygons compared to negative control cells. Of particular note, the three
variables examined for network formation of cells grown on RZ-QK were statistically
equivalent to those of positive control cells.
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Figure 3.4.2 Internalization of acetylated low density lipoprotein (ac-LDL) by cells
differentiated on the RZ-QK protein. Cells were grown on each surface for 12 days. (A)
Fluorescence imaging of cells positive for ac-LDL (white) are shown. Scale bar
represents 100 µm. (B) The percentage of cells positive for ac-LDL was calculated. At
day 12, cells on the RZ-QK protein showed statistically higher ac-LDL internalization
than proliferating cells (day 0) and negative control cells at day 12 and lower
internalization than positive control cells at day 12. Data are represented as the average ±
standard deviation of five replicates. Letters indicate statistically different Tukey groups.
* represents a statistical difference compared to proliferating group at day 0 (p < 0.05) as
assessed by Dunnett’s test.
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Figure 3.4.3 Network formation by cells grown on the RZ-QK protein. Cells were
trypsinized and seeded on ECMatrix after 12 days of differentiation. (A) Phase contrast
images of cells on ECMatrix after 6 h of incubation. Scale bar represents 250 µm. (B)
Network formation in each group was quantified. Cells grown on the RZ-QK protein
exhibited substantially higher total network length, number of branching points, and
number of polygons compared to negative control cells. These variables for cells on the
RZ-QK protein were statistically equivalent to those of positive control cells. Data are
represented as the average ± standard deviation of five replicates. Letters indicate
statistically different Tukey groups.
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Endothelial Marker Expression on RZ-QK:
Endothelial-specific gene expression levels were analyzed by qPCR after 4 days
of differentiation. First, two endothelial-specific markers, VE-cad and PECAM, were
evaluated. Gene expression levels of VE-cad for cells on the RZ-QK protein were
markedly enhanced compared to all groups. The RZ-QK protein induced a 7.7-fold and
1.8-fold increase in VE-cad gene expression compared to the proliferating group at day 0
and negative control at day 4, respectively (Figure 3.4.4A). For the expression level of
PECAM, there was no difference between cells on the RZ-QK protein and negative
control cells (Figure 3.4.4B). For both genes, the expression levels in negative control
cells were higher than those in positive control cells. We also examined gene expression
levels of two other endothelial-specific markers, vWF and VEGF R2, at day 4. However,
those gene expression levels could not be reliably detected as measured levels were very
low (data not shown).

Figure 3.4.4 Expression levels of endothelial genes. The gene expressions were measured
by qPCR after 4 days of differentiation. Endothelial gene expression levels for (A) VEcad, (B) PECAM, (C) Ephrin-B1 were analyzed, normalized by GAPDH, and are shown
relative to the proliferating group at day 0. The gene expression levels of VE-cad and
Ephrin-B1 in cells differentiated on RZ-QK for 4 days were statistically higher than those
of the proliferating (day 0) and negative control groups. Data are represented as the
average ± standard deviation of three to five replicates. Letters indicate statistically
different Tukey groups. * represents a statistical difference compared to the proliferating
group at day 0 (p < 0.05) as assessed by Dunnett‘s test.
In addition, the expression level of Ephrin-B1, which is a marker expressed in
both arteries and veins [127], was assessed and exhibited a 6.7-fold and 1.4-fold increase
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in cells on the RZ-QK protein compared to proliferating cells at day 0 and negative
control cells at day 4, respectively (Figure 3.4.4C). The positive control cells showed a
statistically higher expression level of Ephrin-B1 compared to cells on the RZ-QK
protein. Arterial-specific and venous-specific markers were also examined, but there were
no differences in expression levels of Ephrin-B2 (arterial), EphB4 (venous), or COUPTFII (venous) between cells on the RZ-QK protein and negative control cells (Figure
3.8.2A-C).
The expression of vWF by cells on RZ-QK was assessed at 12 days of
differentiation by immunofluorescence (Figure 3.4.5). The protein expression was
analyzed by evaluating the mean pixel intensity per cell and the intensities of three
replicates were pooled to show the percentage of the population expressing vWF. The
intensity histograms of RZ-QK and positive control groups at day 12 shifted from those
of the proliferating group at day 0 and the negative control at day 12 (Figure 3.4.5B). At
the mean intensity per cell above 130, the percentage of cells expressing vWF was 0.9%
for the proliferating group at day 0 and 3.8% for negative control. In contrast, 29.6% of
cells on RZ-QK and 37.9% of positive control cells expressed vWF.
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Figure 3.4.5 Immunostaining for von Willebrand factor (vWF). The protein expression
for vWF was evaluated at day 0 (proliferating) and day 12 of differentiation. (A)
Fluorescence images show vWF expression (green) and nucleus (red). Scale bar
represents 250 µm. (B) The percentage of cells expressing vWF in each group was
determined. The mean pixel intensity per cell from three replicates was pooled (n > 300
per group) to assess the percentage of population expressing vWF. The intensity
histograms of RZ-QK and positive control groups at day 12 shifted from those of the
proliferating group at day 0 and negative control at day 12. At the mean intensity per cell
above 130, the percentage of cells expressing vWF was 0.9% for the proliferating group
at day 0 and 3.8% for negative control. In contrast, 29.6% of cells on RZ-QK and 37.9%
of cells in the positive control expressed vWF.

Finally, after 12 days of differentiation, VEGF R2 marker expression was
analyzed by Western blot (Figure 3.8.2D). All groups at day 12 showed higher VEGF R2
protein expression than proliferating cells at day 0, but there was no difference in marker
expression between cells on the RZ-QK protein and negative control cells.
Protein Specificity on Endothelial Differentiation:
We investigated whether the increased endothelial function of cells differentiated
on the RZ-QK protein is protein-specific. To do so, cells were cultured on non-interactive
bovine serum albumin (BSA) with a surface density of 2.53 ± 0.8 µg/cm2 (statistically
equivalent to RZ-QK density). On these BSA surfaces, cell viability and metabolic
activity was not adversely affected (Figure 3.8.3A – B), but cell differentiation was not
enhanced compared to the negative control. Specifically, at 12 days of differentiation,
internalization of ac-LDL by cells cultured on BSA surfaces was statistically equivalent
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to that of negative control cells and lower than cells on the RZ-QK protein (Figure
3.4.6A). In addition, cells grown on BSA surfaces remained rounded on ECMatrix and
did not form extensive networks (data not shown). The quantified variables of network
formation for cells grown on BSA surfaces were statistically similar to those of negative
control cells (Figure 3.4.6B). Thus, these data indicate that the composition of RZ-QK,
and not the mere presence of protein, actively promoted endothelial function.
To investigate whether the authentic QK peptide sequence can induce endothelial
differentiation in a sequence-specific manner, we examined cell responses on a negative
control protein, RZ-scQK. The RZ-scQK protein has the same amino acid composition as
the RZ-QK protein does, but the order of amino acids in the QK domain has been
scrambled (Figure 3.8.4A). The RZ-scQK protein was produced and analyzed by the
same methods as the RZ-QK protein (Figure 3.8.4B – C). The density of RZ-scQK, 3.46
± 0.8 µg/cm2, was statistically equivalent to that of RZ-QK. The differentiation results
show that ac-LDL internalization by cells on the RZ-scQK protein did not statistically
differ from that of negative control cells nor from that of cells on the RZ-QK protein
(Figure 3.4.6C). Gene expression levels on the RZ-scQK protein were measured, but
there were no differences in gene expression levels between cells on RZ-QK and RZscQK proteins (Figure 3.8.4D).
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Figure 3.4.6 Examination of specificity of the RZ-QK protein or the QK domain on
endothelial differentiation. Cell differentiation on non-interactive BSA surfaces or the
RZ-scQK protein (i.e., a negative control protein containing scrambled sequence in the
QK domain) was compared to those on the RZ-QK protein. The density of each surface
was statistically equivalent to that of the RZ-QK surface. (A) The percentage of cells
positive for ac-LDL on BSA surfaces was statistically lower than that on the RZ-QK
protein at 12 days of differentiation. (B) After 12 days of culture, the total network length
and the number of branching points per area on BSA surfaces were statistically
equivalent to those of the negative control and lower than those on the RZ-QK protein.
The number of polygons is not shown because there was no polygon formation by cells
cultured on BSA surfaces. Negative control and RZ-QK data is from the same experiment
as shown in Figure 3.4.3B. (C) At 12 days of differentiation, the internalization of acLDL by cells on the RZ-scQK protein did not statistically differ from that of negative
control cells nor from that of cells on the RZ-QK protein. Negative control and RZ-QK
data is from the same experiment as shown in Figure 3.4.2B. Data are represented as the
average ± standard deviation of five replicates. Letters indicate statistically different
Tukey groups. * represents a statistical difference compared to proliferating group at day
0 (p < 0.05) as assessed by Dunnett‘s test.
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Figure 3.4.6 continued.
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3.5

Discussion

Endothelial differentiation of stem cells has been previously achieved using
different culture conditions. For example, mesenchymal stem cells can be differentiated
into endothelial-like cells by serum deprivation [7], shear stimulation [121], or high
seeding density [8]. The most common method is to use growth factors such as VEGF in
low serum conditions. Exogenous VEGF at 50-100 ng/mL increased endothelial–specific
markers including vWF and VE-cad and enhanced endothelial functional behaviors such
as ac-LDL uptake and network formation by cells after 7-14 days of differentiation
compared to proliferating (i.e., undifferentiated) cells [6, 118, 119, 128]. These studies
have focused on promoting differentiation by using growth factors. In contrast, it has
been suggested that endothelial differentiation can be induced by using biomaterials. One
study reported that endothelial differentiation of rat MSCs can be induced by a
synergistic effect of matrix stiffness and VEGF [40]. Another study demonstrated that
VEGF-functionalized titanium promoted endothelial differentiation of hMSCs in the
absence of growth factors [120]. However, there are not many studies examining the
effect of engineered materials on endothelial differentiation of stem cells.
This study illustrates an alternative strategy to promote endothelial differentiation
by utilizing protein-engineered microenvironments without exogenous VEGF. Our
material-based approach has several advantages compared to utilizing soluble growth
factors. Soluble VEGF is routinely used at a concentration of 50 ng/mL [6, 118, 119,
125]. This supra-physiological concentration is approximately 1000 times higher than the
measured concentration of free VEGF in healthy tissues [129]. An excessive amount of
VEGF may lead to vascular leakage and hypotension [130]. However, our protein-based
microenvironments reduce the need for supra-physiological concentrations of growth
factors. In addition, the bioactivity of the material could be retained throughout cell
differentiation. In contrast, soluble VEGF is not effective for long time periods due to its
short half-life (< 30 min) [131], and it may need to be added until the desired
differentiation state is achieved. Thus, the use of our proteins could be more costeffective to promote endothelial differentiation. Third, soluble VEGF could be diffused
away from target differentiation sites whereas the bioactivity of our protein-based
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microenvironments could be retained at the target sites and enable homogeneous
differentiation.
Our results showed that even in the absence of VEGF, protein-based
microenvironments supported hMSC growth and promoted endothelial differentiation of
cells. First, we confirmed that the RZ-QK protein was cytocompatible and supported
normal metabolic activity of hMSCs (Figure 3.4.1). In differentiation studies, we
observed that, in the absence of VEGF, the RZ-QK protein elicited enhanced endothelial
differentiation compared to the negative control group (Figure 3.4.2, Figure 3.4.3, Figure
3.4.4, and Figure 3.4.5). We demonstrated that endothelial function such as uptake of acLDL (Figure 3.4.2) and network formation (Figure 3.4.3) and expression levels of
endothelial genes (Figure 3.4.4A and C) were increased for cells cultured on our protein
for 12 days compared to those of negative control cells. In addition, we observed that ~30%
of cells on the RZ-QK protein expressed vWF marker at 12 days of differentiation,
whereas ~4% of negative control cells expressed vWF (Figure 3.4.5).
Of particular note, network formation of cells on the RZ-QK protein was as robust
as that of positive control cells. For example, the variables used to quantify network
formation were statistically equivalent for cells on the RZ-QK protein and positive
control cells (Figure 3.4.3). Previous studies showed that the same type of medium (i.e.,
PDM) used in our positive control enhanced network formation [6, 118, 119, 128]. Thus,
our result implies that the RZ-QK protein alone had the same effect on promoting
network formation as growth factors, including VEGF, that were used in PDM. In
contrast, the uptake of ac-LDL of cells on the RZ-QK protein was not statistically
equivalent to that of positive control cells. It could be possible to further enhance the cell
responses on the RZ-QK protein through shear stress [121], co-culture with endothelial
cells under hypoxic conditions [132], or mechanical cues [40].
As presented in Figure 3.4.4, we observed an increase in gene expression levels of
VE-cad on the RZ-QK protein at 4 days of differentiation compared to proliferating and
negative control groups. However, there was no significant difference in PECAM gene
expression between the RZ-QK and negative control groups. Unexpectedly, our positive
control cells showed statistically equivalent VE-cad gene expression as proliferating cells.
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Compared to negative and RZ-QK protein groups, positive control cells exhibited
statistically lower gene expression levels of VE-cad and PECAM. One potential reason
for low expression of VE-cad and PECAM in the positive control is that 4 days of
differentiation that we selected may not be right time point to capture upregulation of
these two genes of positive control cells. There were not available literatures
demonstrating time-course expression levels of two genes of cells that had been
endothelially differentiated from adult stem cells. However, other aspects of our positive
control cells such as functional behaviors (Figure 3.4.2 and Figure 3.4.3) and protein
expression (Figure 3.4.5) supported that cells in positive control had been differentiated
towards endothelial lineage at later time point than day 4.
We also investigated whether cells undergo arterial or venous endothelial
differentiation by examining several marker genes. Ephrin-B1, a marker expressed both
in arteries and veins [127], was markedly upregulated in cells on the RZ-QK protein
compared to proliferating and negative control cells (Figure 3.4.4C). Previous studies
demonstrated that Ephrin-B1 is correlated with angiogenic responses as it promoted
proliferation and migration of human endothelial cells in vitro, vessel formation in
tumors [133], and network formation of endothelial cells on Matrigel [134]. Our results
were consistent with these previous observations since the RZ-QK protein enhanced both
Ephrin-B1 gene expression and network formation on ECMatrix.
Next, we evaluated arterial-specific (Ephrin-B2) and venous-specific (EphB4 and
COUP-TFII) genes. There are not many studies that examine the molecular mechanism
of arterial and venous specification from stem cells; however, VEGF and Notch signaling
defines arterial specification by increasing Ephrin-B2 expression [135], whereas COUPTFII maintains vein identity and is required for EphB4 expression [136, 137]. Our results
show that there is no significant difference in arterial or venous gene expression levels
between cells on the RZ-QK protein and negative control cells (Figure S2A-C). However,
we observed that different medium compositions resulted in different patterns in gene
expression levels. BDM without growth factors elicited an increase in venous gene
expression (e.g., EphB4 and COUP-TFII) in the negative control and RZ-QK groups
compared to the proliferating group. As expected based on the literature [135], our results
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showed that PDM containing VEGF at a total concentration of 52 ng/mL promoted
higher arterial expression (e.g., Ephrin-B2) in positive control cells compared to
proliferating cells. Interestingly, PDM also increased the gene expression of COUP-TFII,
which is a venous marker, in the positive control compared to the proliferating group.
Thus, we postulate that cells differentiated in PDM exhibit a mixed phenotype. Arterial
specification is activated from a default venous state by VEGF and Notch signaling [137].
Because we measured gene expression levels at a very early time point (day 4), it is
possible that positive control cells in PDM had just started arterial specification and
therefore exhibited a mixed phenotype.
To ensure that enhanced endothelial differentiation can be attributed to our RZQK protein specifically, we investigated cell differentiation on two control protein
surfaces, BSA and RZ-scQK protein surfaces. We demonstrated that there was no
increase in the uptake of ac-LDL and network formation by cells on non-interactive BSA
surfaces compared to negative control cells (Figure 3.4.6A – B). However, each of those
two responses by cells on BSA surfaces was statistically lower than that on RZ-QK
surfaces at the same protein density (Figure 3.4.6A – B). Thus, the mere presence of
protein on surfaces was insufficient to promote endothelial differentiation of hMSCs, and
the specific composition of the RZ-QK protein appeared to be necessary for promoting
differentiation. Next, the RZ-scQK protein was used to examine the specific role of the
QK peptide on cell differentiation. At the same protein density, there was no significant
difference in internalization of ac-LDL and gene expression levels between cells on RZQK and RZ-scQK proteins (Figure 3.4.6C and Figure 3.8.4D). However, because cells on
the RZ-scQK protein showed statistically equivalent ac-LDL uptake to negative control
cells but those on the RZ-QK protein did not, endothelial function on the RZ-scQK
protein may be at an intermediate stage between that of negative control cells and cells on
the RZ-QK protein. This intermediate cell response may be caused by non-specific
interactions with the amino acids in the RZ-scQK protein.
In this study, we demonstrated that protein-engineered microenvironments can
direct endothelial differentiation of hMSCs and do not require exogenous growth factors.

62
We envision that our proteins can be potentially used to create endothelial cells for use in
vascular grafts for successful vessel reconstruction.
3.6

Conclusions

This work demonstrates an alternative strategy to obtain endothelial cells by using
protein-based microenvironments. We demonstrated that endothelial differentiation of
hMSCs can be induced by our protein-engineered microenvironments in the absence of
exogenous VEGF. First, we showed that the protein was cytocompatible and supported
metabolic activity of cells. Next, we showed that the protein promoted endothelialspecific gene and protein markers and endothelial function. The enhanced cell
differentiation on the RZ-QK protein is protein-specific. Thus, our protein is a promising
tool to obtain endothelial cells for use in vascular grafts.
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3.8

Supporting Information

Western Blot Analysis:
Cells were rinsed with PBS twice and treated with radio immunoprecipitation
assay (RIPA) buffer containing protease and phosphatase inhibitor cocktails and
phenylmethylsulfonyl fluoride (PMSF). Collected cells were frozen at -20 °C before
being assayed. Frozen cells were thawed, vortexed, and centrifuged to remove cell debris,
and the supernatant was collected. To measure the total protein concentration of each
sample, the QuantiPro BCA assay kit was utilized. Briefly, 25 µL of cell lysate was
incubated with an equal amount of the reagent for 1 h at 60 °C, and the absorbance at 562
nm was measured. A standard curve was created using a BSA solution in RIPA buffer to
determine the total protein amount of each sample.
A total of 50 µg of proteins were loaded on a 10% SDS-PAGE gel, and the gel
was run at 125 V for 1.5 h. The proteins were transferred to a nitrocellulose membrane at
55 V for 10 h at 4 °C. The membrane was blocked with 5 (w/v) % dry milk in Trisbuffered saline with Tween-20 (TBST) buffer at 4 °C overnight. The membrane was
incubated with primary antibody (Santa Cruz Biotechnology) in blocking solution for 1.5
h at room temperature and then incubated with horseradish peroxidase (HRP)-tagged
secondary antibody (Santa Cruz Biotechnology, sc-2005) in blocking solution for 1 h at
room temperature. Details concerning the antibodies used in this study are shown inTable
3.8.3. Proteins were detected with a chemiluminescent substrate (Pierce, 32132). The
intensity of the desired band was quantified by ImageJ analysis software (NIH) and
normalized by that of β-actin. The data are shown as the pixel intensity relative to the
proliferating group at day 0. Three replicates per group were examined.
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Table 3.8.1 Primer sequences for quantitative reverse transcription-polymerase chain
reaction.
Gene

Accession
number

Primer sequence (5‘ → 3‘)

Efficiency

Product length (bp)

Reference

VE-cad

NM001795.3

FW

CCAGGACGCTTTC
ACCATTGAGACA

92%

71

[138]

RV

CCAGAGGCTTCAT
GGGCTTGATGATG
TCTATGACCTCGC
CCTCCACAAA
GAACGGTGTCTTC
AGGTTGGTATTTC
A
GTTCTCGACCCCA
ACGTGTT
CAGGCTTCCATTG
GATGTTGA
CTCCTCAACTGTG
CCAAACCA
GGTTATCCAGGCC
CTCCAAA
CAGCTTTGGAAGA
GACCCTGC
GTCCACCTGAGGG
AATGTACA
CTAGGTGGTGATC
TGCCCTC
GGAAAGAGTCAAC
TCGCCG
ACAGTCAGCCGCA
TCTTCTT
TTGACTCCGACCTT
CACCTT

88%

83

[139]

100%

153

[22]

96%

151

[22]

107%

77

Designed

98%

71

Designed

102%

81

[111]

PECAM

NM000442.3

FW
RV

Ephrin-B1

NM004429.4

FW
RV

Ephrin-B2

NM004093.3

FW
RV

EphB4

NM004444.4

FW
RV

COUP-TFII

NM021005.3

FW
RV

GAPDH

NM002046.3

FW
RV
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Table 3.8.2 Amino acid analysis of the RZ-QK protein.
ASX
SER
GLX
GLY
HIS
ARG
THR
ALA
PRO
TYR
VAL
MET
LYS
ILE
LEU
PHE
Total

Observed mol% Calculated mol%
3.49
3.39
12.37
12.43
14.59
14.69
11.40
11.86
4.90
5.08
2.26
1.69
7.39
7.34
12.64
12.43
11.34
11.30
1.22
1.13
0.34
0.00
2.86
3.39
5.70
5.65
0.67
0.56
3.29
3.39
5.56
5.65
100.00
100.00

Table 3.8.3 Antibodies used for Western blot analysis.
Catalog number
VEGF receptor 2
(VEGF R2)
β-actin

sc-6251

Primary antibody
dilution
1:100

Secondary
antibody dilution
1:1000

sc-47778

1:200

1:2000
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Figure 3.8.1 MALDI-TOF mass spectroscopy of the RZ-QK protein. The measured
molecular weight of RZ-QK (18740 Da) was within 29 Da (0.15 %) of the expected
molecular weight (18711 Da).
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Figure 3.8.2 Expression levels of endothelial markers. Gene and protein expression levels
were measured by (A-C) qPCR after 4 days of differentiation and (D) Western blot
analysis after 12 days of differentiation. Arterial and venous gene expression levels for
(A) Ephrin-B2 (arterial), (B) EphB4 (venous), and (C) COUP-TFII (venous) were
normalized by GAPDH levels and are shown relative to the proliferating group at day 0.
(D) VEGF R2 protein expression was examined and shown relative to the proliferating
group (day 0). Data are represented as the average ± standard deviation of three to five
replicates. Letters indicate statistically different Tukey groups. * represents a statistical
difference compared to the proliferating group at day 0 (p < 0.05) as assessed by
Dunnett‘s test.
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Figure 3.8.3 Cell viability and metabolic activity on BSA surfaces. (A) Cell viability on
BSA surfaces (99.5%) was statistically equivalent to that on gelatin surfaces (99.8%)
(left). The cell viability data on gelatin surfaces is from the same experiment as shown in
Figure 3.4.1A. An image of the LIVE/DEAD assay for cells grown on BSA surfaces is
shown (right). Scale bar represents 250 µm. (B) There was no difference in metabolic
activity, as confirmed by one-way ANOVA, between cells on BSA surfaces and negative
control cells at two time points. The negative control data is from the same experiment as
shown in Figure 3.4.1B. Data are represented as the average ± standard deviation of (A)
four or (B) five replicates.
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Figure 3.8.4 Examination of specificity of the QK domain on cell differentiation. (A-C)
The RZ-scQK protein was manufactured and analyzed and (D) gene expression levels of
cells on the RZ-scQK protein were measured. (A) The full amino acid sequence of the
RZ-scQK protein is shown. (B) The purity of the protein was confirmed by SDS-PAGE
gel. The RZ-scQK protein appeared at the expected molecular weight of 18.7 kDa. The
purity was 96.1% as determined by densitometry analysis. (C) MALDI-TOF mass
spectroscopy of the RZ-scQK protein. The measured molecular weight of RZ-QK (18763
Da) was within 52 Da (0.27 %) of the expected molecular weight (18711 Da). (D)
Endothelial gene expression levels of cells cultured on the RZ-scQK protein for 4 days
were assessed by qPCR. For all markers, there was no statistical difference in expression
levels between cells on RZ-QK and RZ-scQK proteins as evaluated by a one-way
ANOVA. The RZ-QK data are from the same experiments shown in Figure 3.4.4A-C and
Figure 3.8.2A-C. Data are represented as the average ± standard deviation of three to
five replicates.
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CHAPTER 4. ENZYMATICALLY CROSSLINKED PROTEIN MATRICES WITH
TUNABLE STIFFNESS FOR ENDOTHELIAL DIFFERENTIATION OF STEM
CELLS

This chapter consists of a manuscript by Kim Y, Gill EE, and Liu JC, prepared for
submission in 2014.

4.1

Abstract

The stiffness of cellular microenvironments has recently received significant
attention. While conventional culture substrates used for endothelial differentiation have
stiffness much higher compared to that of sub-endothelial environments, there have been
few studies examining the effect of matrix stiffness on endothelial differentiation of stem
cells. Thus, the goal of this study was to create relatively soft matrices compared to the
conventional substrates and to evaluate whether human mesenchymal stem cells (hMSCs)
can be differentiated into endothelial-like cells by matrix stiffness. We used tissue
transglutaminase to create protein matrices varying stiffness. We observed that matrix
stiffness modulated spreading and endothelial differentiation of cells, as the stiffest
matrices increased cell spreading and endothelial differentiation compared to the softest
matrices. In addition, endothelial differentiation on our matrices was statistically
equivalent to that on hard glass surface. Thus, our tunable matrix system is a promising
tool to obtain endothelial-like cells and to provide more native sub-endothelial
environments compared to conventional culture substrate.
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4.2

Introduction

In native tissue, cells are surrounded by extracellular matrix containing many
types of microenvironmental cues that affect cell behavior. Microenvironmental cues
consist of biochemical cues (e.g., growth factors and ligands), biophysical cues (e.g.,
stiffness, topography, and shear stress and strain), extracellular matrix proteins (e.g.,
collagen and laminin), and cell-to-cell interaction (e.g., Notch signaling and cadherins)
[20]. These cues interplay with each other in a spatial and temporal manner, thereby
regulating cell behavior.
Among the cues, the stiffness of microenvironment has recently received
significant attention. Many researchers have used cell culture substrate such as glass and
plastic surfaces for in vitro experiments. However, some native tissue environments are
much softer than these hard surfaces. For example, brain and muscle have an elastic
modulus of several hundred Pa and ~12 kPa [140], respectively, whereas tissue culture
plastic or glass surfaces has an elastic modulus of several GPa. This stiffness difference
between cell culture substrate and native tissue may hinder successful translation of in
vitro system to in vivo application. Thus, when designing engineered tissue environments
by using biomaterials, the material stiffness is considered as an important parameter.
There have been many studies demonstrating how the stiffness of twodimensional matrices affects cell behavior. The matrix stiffness can be controlled by the
density of crosslinked networks in the matrix, which is often varied by material and
crosslinker concentrations [54, 141]. Rowlands et al. demonstrated that cell spreading
was dependent upon matrix stiffness as stiffer matrices promoted greater cell spreading
than softer ones [142]. A number of studies have shown that matrix stiffness can specify
stem cell fate towards different lineages such as brain, muscle, and bone [34, 142].
Endothelial cells present on the inner surface of blood vessels and regulate
homeostasis, blood coagulation, and thrombosis [143]. Endothelial cells reside on soft
sub-endothelial matrices that have an indentation modulus of ~3 kPa [144] and show
different behaviors such as migration and vessel formation, depending on matrix stiffness
[145, 146]. For vascular tissue engineering applications, autologous endothelial cells are
an ideal cell source because they minimize immunogenicity issues. However, when
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endothelial cells show dysfunction due to vascular diseases [114], bone marrow
mesenchymal stem cells (MSCs) can serve as an alternative cell source for vascular tissue
construction because of their proliferation capacity and endothelial differentiation
potential. Biochemical cues such as vascular endothelial growth factor (VEGF) have been
used to promote endothelial differentiation of MSCs [6, 120]. However, there have been
few studies showing whether matrix stiffness can induce endothelial differentiation of
stem cells [147].
The goal of this study was to produce crosslinked matrices with varying stiffness
and to evaluate whether endothelial-like cells can be obtained by differentiating stem
cells on the matrices. The crosslinker used in this study is the enzyme transglutaminase,
which is found in a variety of tissues [42]. The transglutaminase-mediated crosslinking is
mild and biocompatible, as previous reports demonstrated that cells seeded on matrices or
encapsulated in hydrogels crosslinked with transglutaminase were viable and did not lose
proliferation capacity [148, 149]. We created protein matrices by crosslinking with
transglutaminase and varied matrix stiffness by changing total protein concentration. We
characterized material properties such as matrix stiffness, swelling ratio, and water
content. Finally, we examined cell viability and proliferation on the matrices and
evaluated how matrix stiffness influences spreading and endothelial differentiation of
human MSCs (hMSCs).
4.3

Materials and Methods

Materials and Reagents:
All materials and reagents were purchased from Sigma-Aldrich unless otherwise
stated.
Protein Production:
Proteins used in this study were designed and produced as previously described
[57]. Briefly, proteins were expressed by inducing with 2.5 mM of isopropyl β-D-1thiogalactopyranoside (IPTG, Denville Scientific) in a fermentor (BioFlo 110, 14 L
capacity, New Brunswick). Protein purification was performed by a combination of
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salting-out and heating methods. The desired proteins were precipitated by adding total
20% ammonium sulfate to lysed cell solution, and undesired proteins were removed by
heating at 75-80 °C for 10 min. Protein purity was evaluated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) analysis followed by densitometry
analysis of the gel using ImageJ software (National Institutes of Health, NIH).
Preparation of Crosslinking Mixture:
For transglutaminase-mediated crosslinking, two buffers were prepared as
previously described [150]. The proteins were dissolved at desired concentrations in icecold buffer containing 50 mM Tris-HCl (pH 8.0), 10 mM CaCl2, and 1 mM
ethylenediaminetetraacetic acid (EDTA). The transglutaminase was dissolved at 4
unit/mL (U/mL) in ice-cold buffer of Tris-HCl (pH 8.0), 10 mM dithiothreitol (DTT), and
1 mM EDTA. An equal amount of the protein and enzyme solutions was mixed, and the
mixture was centrifuged briefly to remove air bubbles before incubation at 37 °C.
For

chemical

crosslinking,

tris(hydroxylmethyl)phosphine

(THP,

Strem

Chemicals) was used. The proteins were dissolved in phosphate-buffered saline (PBS)
and mixed with ice-cold THP in PBS. The molar crosslinking ratio of primary amines in
the proteins to hydroxymethyl phosphine groups in THP was 1:5. The mixture was
centrifuged to remove air bubbles before crosslinking at 37 °C.
Contact Angle Measurement:
The crosslinking mixture was prepared as described in previous section. 48 µL of
the mixture were added to 16-mm-diameter, 250-µm-thick silicone mold (McMaster Carr,
87315K62) on an 18-mm cover glass. Another silicone sheet at a thickness of 500 µ m
(McMaster Carr, 87315K61) was placed on top of the mold. After incubation for 1.5 h at
37 °C in a humid environment, crosslinked protein matrices were cooled to room
temperature overnight in a humid environment and the molds were removed. For contact
angle measurement, excess water was removed by a micropipette, and spreading of PBS
on the matrices was monitored for 1 min by using a Pinnacle studio 8 ATI version. The
contact angle was calculated by using ImageJ software (National Institutes of Health,
NIH).
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Rheological Properties:
Matrix modulus was measured on an AR2000 rheometer (TA Instrument) by
using a 15 mm plate-on-plate geometry. The chilled mixture of proteins and enzyme was
prepared as described in preparation of crosslinking mixture of section 4.3, briefly
centrifuged, and immediately placed onto the bottom plate at 4 °C. The top plate was
lowered and set at a gap distance of 825 µm with a slow rotation to ensure that the
mixture homogeneously contacted the top plate. To prevent gel dehydration during
measurements, mineral oil was used to cover the exposed edge of the mixture. After
increasing the plate temperature to 37 °C, rheological measurements were performed at
that temperature for 1 h. Frequency and strain sweeps were performed at a range of 0.110 rad/s and 0.1-10%, respectively, to determine linear viscoelastic region. Time sweep
was conducted at 1 rad/s of angular frequency and 1% strain. Three replicates per group
were measured.
Swelling Ratio and Water Content Measurements:
The chilled mixture of proteins and enzyme was prepared as described in
preparation of crosslinking mixture of section 4.3, and 20 µL of the mixture was loaded
to 6.5-mm-diameter, 500-µm-thick silicone mold attached on 12-mm-diameter cover
glass. The silicone cover was then placed onto the top of the mold. The constructs were
placed in a humidified incubator at 37 °C for 1 h to allow cross-linking to take place.
After cooling down matrices at room temperature, the molds were removed and the
matrices on cover glasses were incubated in 5 mL PBS at 37 °C.
The whole constructs (i.e., matrices on cover glasses) were weighed at 3 days of
swelling. The excess PBS on the bottom of the cover glass and on the matrix was
removed with a Kimwipe and a micropipette, respectively. The weight of swollen matrix
(Ws) was obtained by subtracting the weight of cover glass that had measured before
matrix fabrication from the weight of swollen matrix on the cover glass. The constructs
were rinsed with Milli-Q water, frozen at -80 °C, and lyophilized. The weight of dry
matrix (Wd) was calculated by subtracting the weight of cover glass from the weight of
dried matrix on the cover glass. The swelling ratio and water content were calculated
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using equations of Ws/ Wd and 100 * (Ws-Wd) / Ws, respectively. Four to five replicates
per group were examined.
Preparation of the RZ-TGase Matrices for Cell Culture:
The mixture of proteins and enzyme was prepared as described in preparation of
crosslinking mixture of section 4.3. 10.5 µL of the mixture were added to 8-mm-diameter,
250-µm-thick silicone mold on a 12-mm cover glass. Another silicone sheet at a
thickness of 500 µm was placed on top of the mold. After incubation for 1.5 h at 37 °C in
a humid environment, crosslinked protein matrices were cooled to room temperature
overnight in a humid environment. The next day, the molds were gently removed, and a
cloning cylinder (Corning, 3166-10) was placed on each cover glass on which the matrix
had been made. To prevent medium leakage from the cloning cylinder during cell culture,
sterile vacuum greases were applied on the bottom of the cylinder. The whole matrix
system was placed into a well of tissue culture polystyrene (TCP). The matrices were
sterilized with 70 (v/v) % ethanol at room temperature for 30 min and rinsed with PBS
for 4 h with several exchanges. Finally, the matrices were incubated overnight at 37 °C
with 5% CO2 in serum-free endothelial basal medium (Lonza, CC-3162) before cell
seeding.
Cell Culture:
hMSCs (Lonza, PT-2501) were cultured at 37 °C with 5% CO2 in a humid
environment. Cells were grown in maintenance medium containing low-glucose DMEM,
10% fetal bovine serum (Lonza, 18-501F), 100 U/mL penicillin, and 100 µg/mL
streptomycin (Invitrogen, 15140-122). For endothelial differentiation, cells were seeded
on cover glasses or protein matrices at a density of 7000 cells/cm2 in the differentiation
medium consisting of endothelial growth medium-2 (Lonza, CC-3162) and additional 50
ng/mL VEGF (R&D Systems, courtesy of the National Cancer Institute Preclinical
Repository). The total VEGF concentration in the differentiation medium was 52 ng/mL.
To avoid the effect of serum variability on cell responses, the differentiation medium
used in this study contained 2% fetal bovine serum (Atlanta Biologics, S11550) from the
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same lot. Cells at passage 4 were used in all experiments. The medium was replaced
every two days.
Live/Dead Cytotoxicity Assay:
The viability of cells on protein matrices was assessed by a LIVE/DEAD kit
(Molecular Probes, L3224). At desired time point, cells on cover glasses or matrices were
incubated in the differentiation medium containing 0.5 µM calcein AM and 0.75 µM
ethidium homodimer-1 (EthD-1) for 40 min at 37 °C. Cells were rinsed with PBS
containing 0.90 mM CaCl2 and 0.49 mM MgCl2, and cells on all surfaces were imaged on
a Nikon Ti-E microscope. Cells on cover glasses that had treated with 70 (v/v) % ethanol
for 30 min served as a control for dead cells. Cell viability was assessed by analyzing live
and dead cells using Nikon NIS-Elements AR software (version 3.2). Three to four
replicates per each group were examined and at least 200 cells per replicate were
examined.
Cell Proliferation:
Cell proliferation was evaluated by CytoScan WST-1 (G-Biosciences, 786212)
and BrdU (Millipore, QIA58) cell proliferation assays. First, cellular metabolic activity
was measured by WST-1 assay. At 1 day after seeding, the reagent was added to medium
at a ratio of 1:10 and incubated for 4 h at 37 °C. The medium were transferred to new
plate and the absorbance was measured by using a SpectraMax M2e (Molecular Devices).
Cellular metabolic activity was determined as the percentage relative to cells on glass
surface. Five to six replicates per group were examined.
Second, after 2 days of seeding, cells were incubated in the differentiation
medium containing BrdU for 24 h and then fixed with 4 (w/v) % formaldehyde in PBS
for 25 min. Cells were rinsed with PBS twice and incubated in 2N HCl for 30 min to
denature DNA. Cells were treated with PBS containing 1 (w/v) % bovine serum albumin
(BSA) and 0.1 (v/v) % triton X-100 for 1 h. Then, cells were incubated for 1 h with antiBrdU antibody, which was diluted in dilution buffer at a ratio of 1:100. Following rinsing
with PBS twice, cells were incubated for 1 h with Alexa Fluor 488-tagged secondary
antibody (Life Technologies, A11001) diluted 1:1000 in 1% BSA solution. Finally,
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nuclei were stained with DRAQ5 (Biostatus, DR50200) diluted 1:500 in PBS. Each
matrix on cover glass was placed on microscope slides and covered by an 18-mm cover
glass with a mounting medium of 50 (v/v) % glycerol in PBS. Cells were imaged with a
20x objective on a Nikon Ti-E microscope, and fluorescence images were analyzed by
Nikon NIS-Elements AR software (version 3.2). The percentage of cells that had
incorporated BrdU was evaluated. Three to five replicates per group were examined and
at least 120 cells per replicate were counted.
Cell Spreading:
After 10 h of seeding, cells on cover glasses or protein matrices were rinsed with
PBS, fixed with 4 (w/v) % formaldehyde in PBS for 30 min, and rinsed with PBS. Cells
were permeabilized with 0.1 (v/v) % triton in PBS for 25 min and stained with a
fluorescein isothiocyanate (FITC)-labeled phalloidin (Sigma, P5282) at 0.5 µg/mL in
PBS for 40 min. Nuclei were stained for 15 min with DRAQ5 (Biostatus, DR50200)
diluted 1:500 in PBS. Each matrix on cover glass was mounted on microscope slide and
covered with an 18-mm cover glass with a mounting medium of 50 (v/v) % glycerol in
PBS. Cells on matrices were imaged using a 20x objective on a Nikon Ti-EC-1 Plus
microscope. Fluorescence images were analyzed by Nikon NIS-Elements AR software
(version 3.2) to quantify cell area and circularity. Each group has four to six replicates
and at least 60 cells were counted per replicate.
Internalization of Acetylated-Low Density Lipoprotein (ac-LDL):
At each time point, cells were reseeded on an 8-well Lab-Tek Chamber Slide
(Thermo Scientific, 154534) at a density of 10,000 cells/cm2 for 4 h. Then, cells were
incubated for 4 h with acetylated-LDL conjugated with 1,1'-dioctadecyl-3,3,3',3'tetramethyl-indocarbocyanine perchlorate (Dil-ac-LDL) (Alfa Aesar, BT-902) at a
concentration of 2 µg/mL. Cells were rinsed with PBS and fixed with 4% formaldehyde
in PBS for 25 min. After washing wells with PBS three times, the chambers were
removed, and the slide was stored in a mounting solution of 50% glycerol in PBS.
The internalization of Dil-ac-LDL by cells was imaged by a TRITC filter cube on
a Nikon Ti-EC-1 Plus microscope. Cells that had internalized Dil-ac-LDL were
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determined by threshold levels at which proliferating group had minimal fluorescence.
Total number of cells per image was counted using phase contrast image, and the
percentage of cells internalized Dil-ac-LDL was evaluated. Four replicates per group
were examined.
Statistical Analysis:
Data are represented as mean ± standard deviation. First, Shapiro-Wilk and
Levene‘s modified tests were used to confirm normality and homogeneity of variance,
respectively. If data satisfied both assumptions, one-way analysis of variance (ANOVA)
followed by Tukey‘s post hoc test were conducted to evaluate statistical differences
between experimental groups. For data showing unequal variances, a Box-Cox
transformation was conducted [80]. Because water content data (Figure 4B) did not show
equal variance even after data transformation, Welch‘s test and Games-Howell test were
performed to evaluate statistical differences between groups. All statistical analyses were
performed by Statistical Analysis Software (SAS, version 9.2) except for water content
data that was analyzed by Minitab (version 17). A statistical significance represents if a
p-value was less than 0.05.
4.4

Results

Production of Proteins and Matrices:
The RZ-RGD and RZ-scRGD proteins were designed and produced as previously
described [57]. The full amino acid sequences of the proteins are shown in Figure 4.4.1A.
Briefly, in the RZ-RGD protein, a resilin-like sequence provides structural integrity and
the RGD cell-binding sequence is included to promote cell adhesion. The RZ-scRGD
protein serves as a negative control protein for cell adhesion as the order of glycine and
aspartic acid residues in the RGD domain has been scrambled to disrupt the interaction
between cells and the RGD sequence. The yield of the RZ-RGD and RZ-scRGD proteins
were 57 and 90 mg per liter of culture, respectively. The purity of the proteins was
confirmed by SDS-PAGE gels followed by densitometry analysis. The RZ-RGD and RZscRGD proteins were 96 and 99% pure, respectively (Figure 4.8.1).
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Figure 4.4.1 Our proteins can form gels by crosslinking with transglutaminase (TGase).
(A) The amino acid sequences of proteins used in this study are shown. In the RZ-RGD
protein, the RGD cell-binding sequence is included on the C-terminus of resilin structural
domain to promote cell adhesion. The RZ-scRGD protein serves as a sequence-scrambled
negative control protein for cell adhesion. Bold letters represent glutamine and lysine
residues that are used for TGase-mediated crosslinking. (B) The crosslinking reaction
between the RZ proteins is shown. Top: In the presence of calcium ions, TGase can form
covalent bonds between a primary amine of lysine residues and a γ-carboxamide group of
glutamine residues. Red indicates the resilin domain and blue indicates the RGD or
scrambled domain, respectively. Bottom: The uncrosslinked solution containing the
proteins and TGase (left) becomes a white crosslinked gel (right) upon incubation at 37
˚C. The protein and TGase concentration used in this figure were 6% and 2 U/mL,
respectively.
In this study, we chose transglutaminase to create crosslinked matrices, hereafter
referred to as the RZ-TGase matrices. Transglutaminase forms ε-(γ-glutamyl) lysine
amide bonds between a γ-carboxamide group of glutamine (Q) and a primary amine
group of lysine (K) in the RZ proteins, as presented in Figure 4.4.1B. There are twenty
two glutamines and seven lysine residues in each protein, and most of them (i.e., 87%)
are placed in the resilin structural domain. The RGD domain or scrambled domain is not
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involved in TGase-mediated crosslinking because there are no glutamine or lysine
residues in these domains. Upon crosslinking at 37 °C in the presence of calcium ions, a
clear mixture containing the RZ proteins and enzyme became a white crosslinked gel
(Figure 4.4.1B).
Resilin-based proteins can be crosslinked with amine-reactive chemical
crosslinkers, such as tris(hydroxymethyl)phosphino]propionic acid (THPP) [58] or
tris(hydroxylmethyl)phosphine (THP) [54, 57]. Unlike these chemical crosslinkers,
transglutaminase mediates crosslinking reactions and does not exist in a crosslinked
network (Figure 4.4.1B). Our preliminary experiments found that cell attachment was
different on crosslinked matrices, depending on crosslinking chemistry. The RZ-TGase
matrices and chemically crosslinked RZ-THP matrices were produced at 6 and 12% and
both crosslinking chemistries did not disrupt the RGD domain in the RZ-RGD protein.
The surface contact angle and the number of cells at 10-16 h after seeding were similar
on both matrices at each concentration (data not shown). However, at a later time point at
day 6-7, fewer cells were observed on the RZ-THP matrices than the RZ-TGase matrices,
especially at high protein concentration (Figure 4.4.2). This result suggests that cell
attachment may be dependent on crosslinking chemistry, as we observed weaker cell
attachment on the RZ-THP matrices compared to the RZ-TGase matrices.
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Figure 4.4.2 hMSC attachment was different on crosslinked matrices, depending on
crosslinking chemistry. Cell viability on enzymatically crosslinked RZ-TGase matrices or
chemically crosslinked RZ-THP matrices was examined at 6-7 days by LIVE/DEAD
assay. Images of LIVE/DEAD assay are shown. Live cells are green, and dead cells are
red. At both concentrations, cell number was much lower on the RZ-THP matrices
compared to the RZ-TGase matrices. Of particular, few cells were found on 12% RZTHP matrices. Dashed lines indicate the edge of the matrices. Scale bar represents 500
µm.
Mechanical Properties of the RZ-TGase Matrices:
To create the RZ-TGase matrices with a range of stiffness, we varied the total
protein concentration (Figure 4.4.3A). Because previous reports suggest that RGD
density on matrices can also affect cell behavior [68, 151], we maintained constant RGD
density for all matrices by mixing the RZ-RGD protein with the RZ-scRGD protein. The
enzyme concentration was chosen at 2 U/mL, at which homogeneous matrices were
formed at all concentrations within a relatively short time (i.e., less than 6 min).
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Figure 4.4.3 Mechanical properties of the RZ-TGase matrices can be tuned by total
protein concentration. (A) Summary of crosslinking conditions and measurement results
are shown. (B) A strain sweep was conducted on the RZ-TGase matrices at 37 °C over a
range of 0.1 to 10% to determine linear viscoelastic region. (C) A frequency sweep was
performed at 37 °C with a range of 0.1 to 10 rad/s. All storage moduli were independent
on the tested frequency range. (D) Average moduli of the matrices at all concentrations
were statistically different from each other. Letters indicate statistically different Tukey
groups. All data are represented as the average ± standard deviation of three replicates.
We measured bulk mechanical properties of the RZ-TGase matrices on a
rheometer at 37 °C. First, the linear viscoelastic region was determined by performing a
strain sweep in a range from 0.1 to 10% strain at a frequency of 1 rad/s (Figure 4.4.3B).
The storage modulus (G‘), which is a measure of material elasticity, remained constant
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and was independent of strain at all concentrations. Thus, all subsequent experiments
were performed at 1% strain which was within the linear viscoelastic region. A frequency
sweep was performed in a range of 0.1 to 10 rad/s, and showed that the RZ-TGase
matrices at all concentrations were stable over the tested frequency range (Figure 4.4.3C).
Time sweeps of the RZ-TGase matrices were performed at 37 °C (Figure 4.8.2)
and gelation time was determined as the time when the storage modulus exceeded the
loss modulus (G‘‘). Average gelation time increased from 57 s for 6% matrices to 336 s
for 12% matrices (Figure 4.4.3A), suggesting that gelation time depends on total protein
concentration. The shear moduli of the matrices are presented in Figure 4.4.3A and D.
The average G‘ varied from 44 Pa for 6% matrices to 7072 Pa for 12% matrices, and G‘
were one or two orders of magnitude higher than G‖ at all concentrations (Figure 4.8.2).
Shear moduli at all concentration were statistically different from each other (p < 0.05,
Tukey’s post hoc test) (Figure 4.4.3D). Thus, matrix stiffness was easily tuned by varying
total protein concentration.
Characterization of the RZ-TGase Matrices:
Swelling ratio and water content of the RZ-TGase matrices were evaluated
(Figure 4.4.4). The matrices were produced on cover glasses and soaked in PBS at 37 °C
for 3 days. We observed that all matrices reached swelling equilibrium after 3 days of
swelling as there was no significant change in swelling ratio of each matrix at that time
(data not shown). After 3 days of swelling, swelling ratios of 6, 8, 10, and 12% matrices
were 13.2, 10.5, 9.4, and 8.4, respectively, and they were statistically different from each
other (p < 0.05, Tukey’s post hoc test). The percentage of water content of 6, 8, 10, and
12% matrices was 92.4, 90.5, 89.4, and 88.0%, respectively, and the water content of 6%
matrices was statistically different from that of 12% matrices (p < 0.05, Games-Howell
test). Overall, we observed a decreasing trend in swelling ratio and water content as the
degree of crosslinking increased.
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Figure 4.4.4 Swelling ratio and water content of the RZ-TGase matrices. (A) Equilibrium
swelling ratios of the matrices were measured after 3 days of incubation in PBS at 37 °C.
The swelling ratio decreased as total protein concentration increased. (B) The percentage
of water content of the matrices is shown. The percentage of water content of 6%
matrices was statistically higher than that of 12% matrices. Letters indicate statistically
different (A) Tukey groups or (B) statistically different groups determined by GamesHowell test. Data are represented as the average ± standard deviation of four to five
replicates.
Cell Viability and Proliferation on the RZ-TGase Matrices:
First, hMSC viability on the matrices was determined by LIVE/DEAD assay. As
shown in Figure 4.4.5, cell viability on the RZ-TGase matrices or glass surface was at
least 94.0% at day 2, and there was no statistical difference in cell viability between
groups (p > 0.05, one-way ANOVA). At a later time point at day 7, cells on matrices
remained highly viable (Figure 4.8.3). This result suggests that the RZ-TGase matrices
are cytocompatible. Next, cellular metabolic activity on the matrices was measured by
WST-1 assay (Figure 4.4.6A). After 1 day of seeding, hMSCs on the matrices exhibited
statistically equivalent metabolic activity. Cellular metabolic activity on the matrices was
statistically lower than that on glass surface, because metabolic activity is related to cell
number and lower cell number was observed on the matrices than glass surface (Figure
4.4.5A). Finally, cell proliferation on the matrices was evaluated by BrdU cell
proliferation assay (Figure 4.4.6B-C), which measures BrdU incorporation by actively
proliferating cells. After 2 days, cells on all surfaces were incubated with BrdU for 24 h.
The percentage of cells which had incorporated BrdU on the matrices was 50-57% while
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that on glass surface was 71%. Overall, cell viability and proliferation were equivalent on
all RZ-TGase matrices.

Figure 4.4.5 hMSCs were viable on the RZ-TGase matrices. (A) Cells were grown on
glass surface or on matrices for 2 days, and cell viability was evaluated by LIVE/DEAD
assay. Images of LIVE/DEAD assay are shown. Live cells are green, and dead cells are
red. Dashed lines indicate the edge of the matrices. Scale bar represents 500 µm. (B) Cell
viability at day 2 was quantified. Cells showed at least 94.0% viability on all surfaces,
and there was no significant difference in cell viability between groups as confirmed by
one-way ANOVA (p > 0.05). Data are represented as the average ± standard deviation of
three to four replicates.
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Figure 4.4.6 hMSC proliferation on the RZ-TGase matrices was measured. (A) Metabolic
activity of cells on the matrices was assessed by the WST-1 assay at day 1, and the results
are shown relative to metabolic activity of cells on glass surface. Cellular metabolic
activity on all RZ-TGase matrices was statistically equivalent each other, and
significantly lower compared to that on glass surface. This difference in metabolic
activity between the matrices and glass surface could be due to lower cell number on the
matrices compared to glass surface. (B) BrdU cell proliferation assay was performed to
evaluate BrdU incorporation by actively proliferating cells. After 2 days, cells on glass or
on the matrices were incubated with BrdU for 24 h, and BrdU incorporation was
quantified by evaluating the percentage of BrdU-incorporated cells. The percentage of
BrdU-positive cells on the matrices was 50-57%, while that on glass surface was 71%. (C)
Images of the BrdU assay are shown. Green and red indicate incorporated BrdU and
nuclei, respectively. Scale bar represents 100 µm. Letters indicate statistically different
Tukey groups. Data are represented as the average ± standard deviation of three to five
replicates.
Cell Spreading Depends on Matrix Stiffness:
Cell spreading on the RZ-TGase matrices was examined at 10 h after seeding by
fluorescently staining actin stress fibers. Because the solution of the RZ-RGD and RZscRGD proteins was pre-mixed and then underwent crosslinking, we assumed that RGD
ligands were uniformly distributed throughout matrices and did not influence cell
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spreading. Figure 4.4.7A shows hMSC morphology on matrices varying stiffness. Cells
on the softest matrices (i.e., 6%) showed a round morphology, whereas cells on the
stiffest matrices (i.e., 12%) exhibited extensive spreading. Cells on the matrices with an
intermediate stiffness (i.e., 8 and 10%) showed an intermediate spreading behavior
between those on the softest and stiffest matrices. Quantitative analysis of cell spreading
was performed by evaluating cell area and circularity (Figure 4.4.7B). On the softest
matrices, cells exhibited the smallest cell area and the greatest circularity. In contrast,
cells on the stiffest matrices showed the largest cell area and the smallest circularity. Of
particular, these two variables for cell spreading were statistically equivalent on the
stiffest matrices and glass surface. Overall, our results suggest that the stiffness of the
RZ-TGase matrices can modulate cell spreading.
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Figure 4.4.7 hMSC spreading on the matrices was dependent on matrix stiffness. (A)
Actin stress fibers of cells on the matrices were stained after 10 h of seeding. Green and
red represent actin fibers and nuclei, respectively. Scale bar represents 100 µm. (B) Cell
spreading was quantified by evaluating cell area and circularity. Cells on 6% matrices
exhibited the smallest cell area and greatest circularity, whereas cells on 12% matrices
showed the greatest cell area and smallest circularity. Letters indicate statistically
different Tukey groups. Data are represented as the average ± standard deviation of four
to six replicates.
Matrix Stiffness Modulates Endothelial Differentiation of hMSCs:
Endothelial differentiation of hMSCs on the RZ-TGase matrices was evaluated by
functional behavior of endothelially differentiated cells. The internalization of ac-LDL is
a characteristic behavior of endothelial cells [152], and previous studies showed that
endothelially differentiated cells showed a similar behavior to mature endothelial cells
[118, 119]. After 14 days of differentiation, ac-LDL internalization by cells on matrices
was examined by ac-LDL uptake assay (Figure 4.4.8). Cells on glass surface served as
our positive control for endothelial differentiation, because previous reports demonstrated
that MSCs can be differentiated into endothelial lineage on hard surfaces in the presence
of VEGF [6].
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Figure 4.4.8 Endothelial differentiation of hMSCs was modulated by matrix stiffness.
The internalization of acetylated low density lipoprotein (ac-LDL) by cells on the RZTGase matrices was evaluated after 14 days of differentiation by ac-LDL uptake assay.
The percentage of cells that had internalized ac-LDL was quantified. The result shows
that ac-LDL internalization by cells on all matrices at day 14 was statistically higher
compared to that of proliferating cells at day 0 (prolif) and statistically equivalent to that
on glass surface at day 14. At day 14, the uptake of ac-LDL by cells on 12% matrices was
higher compared to that on 6% matrices. Letters indicate statistically different Tukey
groups. Data are represented as the average ± standard deviation of four replicates.
At day 0, only 1.32% of proliferating cells internalized ac-LDL. In contrast, at
day 14, all groups showed increased ac-LDL internalization, compared to proliferating
group. The percentage of cells positive for ac-LDL was 38.7 ± 27.7% on 6% matrices and
77.7 ± 6.7% on 12% matrices, both of which were statistically different from each other
(p < 0.05, Tukey’s post hoc test). This observation suggests that the 7072 Pa stiffness of
12% matrices promoted higher endothelial differentiation compared to the 44 Pa stiffness
of 6% matrices. In addition, cells on all matrices at day 14 showed statistically equivalent
ac-LDL internalization to cells on glass surface at day 14.

4.5

Discussion

Cells are exposed to many environmental cues that affect cell response. Among
the cues, microenvironment stiffness and its effect on cell response have been widely
recognized and studied. Upon adhesion on a matrix (or substrate), a cell generates
contractile forces that are transmitted to the matrix [153]. The matrix resists deformation
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depending on its stiffness and in turn the cell responds to this resistance force. This cellmatrix interaction is associated with adhesion molecules (e.g., integrins) and cellular
cytoskeleton and regulates cell behavior on the matrix.
Matrices have been produced with different chemistries and their stiffness was
tuned by changing chemical crosslinker concentration [141], enzyme concentration [154],
and crosslinking time (i.e., photopolymerization time) [147, 155]. In our study, we have
utilized enzyme-mediated crosslinking to create protein matrices and varied matrix
stiffness by changing protein concentration at a fixed enzyme concentration.
Transglutaminase is an enzyme found in a variety of tissues, such as brain and skin, and
plays a role in stabilization and remodeling of extracellular matrix and wound healing
process [42]. Because of its natural origin and mild crosslinking conditions, tissuederived transglutaminase has been employed to create matrices and hydrogels [148, 156],
and to functionalize materials with biomolecules [157, 158].
The RZ-RGD and RZ-scRGD proteins used in this study contain glutamine and
lysine residues that participate in transglutaminase-mediated crosslinking (Figure 4.4.1).
We have tuned matrix stiffness over two orders of magnitude. Our RZ-TGase matrices
can be categorized into three groups by their stiffness: softest, intermediate, and stiffest
matrices. As shown in Figure 4.4.3A and D, the softest, intermediate, and stiffest
matrices had a 44, 91-402, and 7072 Pa of modulus, respectively. The fast gelation time
(Figure 4.8.2) and frequency- and strain-independent behaviors of all our matrices
(Figure 4.4.3B-C) were similar to those of other resilin-based protein gels that had been
chemically crosslinked [57, 58, 159]. We have characterized swelling ratio and water
content of the matrices (Figure 4.4.4). Because higher protein concentration resulted in
denser crosslinked network, matrices produced at high protein concentration showed
lower swelling ratio and water content compared to those at low concentration.
Our results suggest that the degree of matrix stiffness did not affect viability and
proliferation of cells on the matrices (Figure 4.4.5 and Figure 4.4.6). However, compared
to cells on glass surface, cells on our matrices showed reduced proliferation (Figure
4.4.6), which has been observed by cells on soft matrices with stiffness of 1 kPa [160].
Matrix stiffness influenced cell spreading (Figure 4.4.7), as many studies previously
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demonstrated [155, 161, 162]. We observed that cells developed a broader morphology
on the stiffest matrices at 7072 Pa, whereas cells exhibited small and rounded
morphology on the softest matrices at 44 Pa (Figure 4.4.7). Of particular, cells on the
stiffest matrices exhibited statistically equivalent spreading behavior to those on hard
glass surface. Cell circularity, which implies cell polarization (i.e., indicator of
asymmetrical cell shape), was the highest and lowest on the softest and stiffest matrices,
respectively (Figure 4.4.7B). Previous report suggests that cell polarization is dependent
upon matrix stiffness and controlled by focal adhesion [163].
Given the fact that endothelial cells present on soft, native environments with a
modulus of 3000 Pa [144], tissue culture plastic or glass that were routinely used for in
vitro experiments cannot mimic sub-endothelial environments. Previous studies reported
matrix stiffness suitable for endothelial function and endothelial differentiation. For
example, endothelial cells exhibit network formation on soft matrices such as Matrigel
that has a shear modulus of 100 Pa [164]. This network formation by endothelial cells
failed when the matrix modulus was above 2500 Pa [146]. Similarly, one study showed
that endothelial differentiation of stem cells was influenced by matrix stiffness. It
demonstrated that the matrix with a shear modulus of 150 Pa (or compressive modulus of
2 kPa) increased endothelial marker expression of rat MSCs compared to the matrix with
the modulus of 250 Pa (or compressive modulus of 17 kPa) [147].
We showed that endothelial differentiation of hMSCs was achieved even on softer
environments than glass surface, as internalization of ac-LDL by cells on our matrices
was statistically equivalent to that on glass surface (Figure 4.4.8). This observation
implies that the use of our matrices may be beneficial for endothelial cell differentiation,
because our matrices have stiffness close to that of subendothelium and thus more closely
mimic native endothelial cell environments compared to glass surface. In addition, cell
differentiation was modulated by matrix stiffness; the internalization of ac-LDL by cells
was statistically higher on the stiffest matrices at 7072 Pa, compared to the softest
matrices at 44 Pa. Overall, our result indicates that matrix stiffness can serve as
microenvironmental cues to induce endothelial differentiation of stem cells.
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4.6

Conclusions

In our study, we created protein matrices by crosslinking with transglutaminase,
and tuned matrix stiffness between 44 to 7072 Pa by varying total protein concentration.
The matrices were characterized by evaluating swelling ratio and water content and both
variables decreased as the degree of crosslinking increased. We showed that hMSCs were
viable and proliferated on the matrices. In addition, matrix stiffness modulated spreading
and endothelial differentiation of hMSCs, as we observed that the stiffest matrices
increased cell spreading and differentiation compared to the softest matrices. Finally,
endothelial differentiation on our matrices was statistically equivalent to that on glass
surface. Thus, our tunable matrix system is a promising tool to obtain endothelial-like
cells and to provide more native sub-endothelial environments compared to conventional
culture substrate.
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4.8

Supporting Information

Figure 4.8.1 The purity of the RZ-RGD and RZ-scRGD proteins used in this study was
assessed by SDS-PAGE analysis. Both proteins appeared near the expected molecular
weight of 18.6 kDa. The purity was confirmed by densitometry analysis, which was 96%
for the RZ-RGD protein and 99% for the RZ-scRGD protein.
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Figure 4.8.2 Time sweeps of the RZ-TGase matrices were conducted at 37 ˚C with
angular frequency at 1 rad/s and 1% strain for 1 h. The total protein concentration of the
matrices was at (A) 6, (B) 8, (C) 10, or (D) 12%. Crosslinking occurred within 6 min
upon incubation at 37 ˚C. G‘ (black) and G‘‘ (gray) represent storage and loss moduli,
respectively.
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Figure 4.8.3 hMSCs were viable at 7 days. Cell viability was evaluated by LIVE/DEAD
assay, and images of LIVE/DEAD are shown. Live cells are green, and dead cells are red.
Images of 6 and 12% matrices are from the same experiment as shown in Figure 4.4.2.
Dashed lines indicate the edge of matrices. Scale bar represents 500 µm.

96

CHAPTER 5. CONCLUSIONS

5.1

Summary

This work demonstrated that protein-engineered microenvironments can be
promising tools for tissue engineering applications. The microenvironments were created
by surfaces or matrices of proteins that contain a resilin-like sequence. Our
microenvironments were cytocompatible and supported proliferation of human
mesenchymal stem cells (hMSCs). Differentiation of hMSCs was modulated by
biochemical or biophysical cues in the protein-based microenvironments.
First, a peptide derived from bone morphogenetic protein-2 (i.e., BMP-2 peptide)
was incorporated into our modular proteins. Within the context of our proteins, the BMP2 peptide was active and accelerated osteogenic differentiation of human mesenchymal
stem cells (hMSCs) as it increased alkaline phosphatase activity, calcium deposition, and
expression of bone-related genes. Interestingly, the BMP-2 peptide did not synergize with
the RGD cell-binding sequence within the context of our modular proteins.
Second, cell differentiation toward different lineages was achieved by switching
biochemical cues in our microenvironments. We replaced the BMP-2 peptide with a
peptide derived from vascular endothelial growth factor (i.e., QK peptide) in our proteins.
The surface of our proteins containing the QK peptide promoted endothelial
differentiation of hMSCs in the absence of exogenous growth factors as they increased
endothelial gene and protein expression and endothelial functions compared to negative
control surfaces (i.e., tissue culture plastic). Of particular note, hMSCs on proteins
containing the QK peptide induced statistically equivalent network formation to positive
control cells.
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Finally, biophysical cues in our protein-based microenvironments influenced cell
response, including endothelial differentiation. The proteins contain the RGD cellbinding sequence to promote cell adhesion. Protein matrices were created with tissue
transglutaminase, and the matrix stiffness was tuned by varying total protein
concentration. The matrix stiffness modulated spreading and differentiation of hMSCs as
the stiffest matrices promoted greater cell spreading and higher endothelial differentiation
compared to the softest matrices.
5.2

Future Directions

This work demonstrated that the BMP-2 peptide in modular RZ-BMP proteins
accelerated osteogenic differentiation of hMSCs. In addition, we showed that the BMP-2
peptide did not synergize with the RGD cell-binding sequence within the context of our
modular proteins. The work of Moore et al. demonstrated that the surface concentration
and mode of presentation (i.e., single or combinatorial) of both peptides grafted on
surfaces affected osteogenic differentiation [27]. Thus, future work will investigate the
combination and surface density of BMP-2 and RGD within the context of proteins that
influence osteogenic differentiation of hMSCs.
There have been studies showing the effect of matrix stiffness on osteogenic
differentiation. Engler et al. demonstrated that matrix stiffness of 25-40 kPa induced
osteogenic differentiation of hMSCs [34]. Zouani et al. showed that the BMP-2 peptide
presented on matrices had different effects on osteogenic differentiation depending on
matrix stiffness. When the BMP-2 peptide was immobilized on a matrix with stiffness of
0.5-3.5 kPa, it had no effect on differentiation whereas the peptide immobilized on a
matrix with stiffness of 45-49 kPa increased differentiation [39]. Therefore, future studies
will examine the interplay of matrix stiffness and the BMP-2 peptide incorporated in
crosslinked RZ-BMP matrices on osteogenic differentiation.
This work also showed that our RZ-QK proteins promoted endothelial
differentiation of hMSCs. Previous reports demonstrated that full-length BMP-2 and
VEGF had a synergistic effect on bone formation and angiogenesis (i.e., formation of
new blood vessels). Peng et al. showed that VEGF increased BMP-2-induced bone
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formation in vivo through enhancing angiogenesis. Furthermore, the ratio of VEGF and
BMP-2 affected the degree of bone formation [165]. Another study showed that the
combination of BMP-2 and VEGF enhanced endothelial cell migration and network
formation compared to either BMP-2 or VEGF alone [166]. Thus, future studies will
examine the combinatorial effect of the BMP-2 peptide and the QK peptide on osteogenic
or endothelial differentiation of hMSCs.
Finally, this work demonstrated that endothelial differentiation was achieved on
soft matrices compared to conventional hard surfaces, and the matrix stiffness modulated
endothelial differentiation of hMSCs. Given the fact that endothelial cells reside on the
inner surface of blood vessels, Lee et al. produced tubular vasculature containing an
endothelial cell layer by rolling nanofibrous substrates [167]. Future studies will
investigate the construction of a three-dimensional (3D) vascular structure by using
endothelial-like cell-laden RZ-TGase matrices.
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Appendix A

Molecular Cloning

DNA sequences encoding proteins used in Chapters 2 (i.e., RZ-BMP and RZ-scBMP)
and 3 (i.e., RZ-QK and RZ-scQK) are shown. The BMP-2 and QK peptide sequences are
derived from full-length BMP-2 and VEGF, respectively. Sequence-scrambled proteins
such as RZ-scBMP and RZ-scQK served as negative control proteins.
DNA oligonucleotides for bioactive domains (BA) were purchased from Sigma in the
50 nanomolar scale. All cloning was modeled with Geneious Pro software and performed
using the scheme shown in Figure A.1. Full DNA sequences of pET28aRW-RZ10-BA
(only single stranded DNA) and the corresponding amino acid sequences with important
restriction sites are shown in Figure A.2, Figure A.3, Figure A.4, and Figure A.5. The
amino acid sequences of resilin and bioactive domains are shown in red and blue,
respectively.

Figure A.1 Cloning scheme to construct DNA encoding proteins used in this thesis
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Figure A.2 DNA sequence of pET28aRW-RZ10-QK vector encoding amino acids of RZQK
DNA sequences encoding RZ-scQK, RZ-BMP, and RZ-scBMP proteins in
pET28aRW-RZ10-sQK, pET28aRW-RZ10-BMP, and pET28aRW-RZ10-sBMP vectors
are exactly the same as that of pET28aRW-RZ10-QK vector except for the amino acid
sequence in the bioactive domain between the XhoI and BsmI restriction sites.

Figure A.3 DNA sequence of pET28aRW-RZ10-sQK vector encoding amino acids in
bioactive domain of the RZ-scQK protein.

Figure A.4 DNA sequence of pET28aRW-RZ10-BMP vector encoding amino acids in
bioactive domain of the RZ-BMP protein.

113

Figure A.5 DNA sequence of pET28aRW-RZ10-sBMP vector encoding amino acids in
bioactive domain of the RZ-scBMP protein
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Appendix B

Protein Expression and Purification

Figure B.1 Purification conditions of resilin-based proteins were screened by (A) testing
different amounts of ammonium sulfate in the salting-out step and (B) testing different
orders of the heating and dialysis steps. (A) The protein containing thirty repeats of the
resilin sequence and the RGD sequence (RZ30-RGD) was purified by adding 5, 10, 15,
20, 25, or 30% ammonium sulfate to the lysed cell solution. The results suggest that 20%
ammonium sulfate is necessary to precipitate out the desired protein from the lysed cell
solution. P: pellets resuspended in water at 50 mg/mL, S: supernatant from salting-out
step. The red arrow indicates the expected molecular weight of RZ30-RGD at 48.8 kDa.
(B) The protein containing ten repeats of the resilin sequence and the VEGF-mimicking
peptide (RZ-QK) was purified by changing the order of the heating and dialysis steps.
The results show that the order of the heating and dialysis steps did not affect protein
purity. Lanes 1 and 2: 20% samples that were dialyzed before heating. Lanes 3-5:
samples that were heated first without pre-dialysis. DHP: dialyzed and heated, heat
pellets, DHS: dialyzed and heated, heat supernatant, HS: heat supernatant, HSD: heat
supernatant which was dialyzed after heating, HP: heat pellets.
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Appendix C

Endothelial Differentiation and Condition

To prevent lot-to-lot variability of serum, fetal bovine serum (FBS) was screened for
endothelial differentiation of human mesenchymal stem cells (hMSCs). Two types of
FBS from Atlanta Biologics (hereafter referred to as Atlanta) and Thermo Scientific
(referred to as Thermo) were purchased and tested with endothelial differentiation assays.
Cells at P4 were cultured in endothelial basal medium (EBM) or endothelial growth
medium (EGM). Both EBM and EGM contained 2% serum from either Atlanta or
Thermo whereas maintenance medium (MM) contained 10% serum from Lonza.
As a result, endothelial differentiation of human MSCs was improved with FBS
from Atlanta Biologics (Cat number S11595, Lot number E12070) as cells in EGM
exhibited increased ac-LDL internalization and network formation compared to those in
EBM (Figure C.1). Therefore, the FBS from Atlanta Biologics was chosen for all
differentiation experiments described in this thesis.
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Figure C.1 Cell proliferation and differentiation in different sera were examined. (A)
Metabolic activity of human MSCs differentiated in endothelial media containing
different sera was measured at day 13 of differentiation by WST-1 assay. Metabolic
activity of cells grown in EGM was higher than that in EBM due to the presence of
growth factors in EGM. There was no statistical difference in metabolic activity of cells
grown in the two types of EGM. Letters indicate statistically different Tukey groups. (B)
The internalization of ac-LDL by cells was evaluated after 7 days of differentiation by acLDL uptake assay. With Atlanta FBS, there was a significant difference in ac-LDL
internalization between cells grown in EBM and EGM. Scale bar represents 50 µm. (C)
Network formation was examined after 15 days of differentiation by an in vitro
angiogenesis assay. More significant network formation was observed by cells
differentiated in EGM containing Atlanta FBS. The images were taken after 7 h
incubation on ECMatrix. Scale bar represents 200 µm.
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Using the serum from Atlanta Biologics, endothelial differentiation conditions
were furthered tested by flow cytometry as shown in Figure C.2. At 2 weeks of
differentiation, cells grown in EGM containing additional VEGF at 50 ng/mL enhanced
CD34 and CD144 markers and increased internalization of ac-LDL compared to cells
grown in EBM.

Figure C.2 Endothelial differentiation of human MSCs was evaluated by flow cytometry.
Cells were differentiated for 14 days in EBM or EGM supplemented with additional
VEGF at 50 ng/mL (EGM+VEGF). The EGM+VEGF medium is the same as the positive
differentiation medium (PDM) used in Chapters 3 and 4 and contained a total VEGF
concentration at 52 ng/mL. At 14 days of differentiation in the EGM+VEGF medium, a
few cells started to express CD 34 and CD 144 markers, and 45.8% cells internalized acLDL. Numbers at the top and bottom right of each figure indicate cells exhibiting
significant marker expression above the threshold and cells that did not significantly
express markers, respectively.
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In addition, we investigated whether adding VEGF at 50 ng/mL to EGM
enhanced endothelial differentiation. First, cells grown in EGM containing additional
VEGF at 50 ng/mL had increased ac-LDL internalization at day 12 compared to
proliferating cells at day 0 and cells grown in EBM at day 12 (Figure C.3). However, the
presence of VEGF at 50 ng/mL in EGM did not improve ac-LDL internalization as there
was no significant difference in ac-LDL internalization by cells grown in EGM-VEGF
and EGM+VEGF media (Figure C.4). EGM-VEGF media contained VEGF from the kit
at 2 ng/mL, whereas EGM+VEGF media contained the total VEGF concentration at 52
ng/mL.

Figure C.3 Endothelial differentiation conditions of human MSCs was screened by
culturing cells in different types of media. Cells were grown in EBM or EGM+VEGF
media, and cell differentiation was evaluated by ac-LDL internalization at day 0
(proliferating) and 12. The total VEGF concentration in EGM+VEGF medium was 52
ng/mL. At day 12, the EGM+VEGF group exhibited higher ac-LDL internalization than
proliferating and EBM groups. Letters indicate statistically different Tukey groups.
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Figure C.4 Endothelial differentiation conditions of human MSCs was screened by
culturing cells in different types of medium and evaluating ac-LDL internalization. Cells
were grown in EGM without VEGF (EGM-VEGF) or EGM+VEGF. At day 12, there was
no statistical difference in ac-LDL internalization between cells grown in EGM-VEGF
and EGM+VEGF groups. Letters indicate statistically different Tukey groups.
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Appendix D

Resilin-based Protein Films

Figure D.1 Chemically-crosslinked resilin-based protein films were confirmed by
colorimetric Western blot. The RZ-scQK protein containing ten repeats of resilin was
adsorbed on coverglasses overnight and crosslinked with tris (hydroxymethyl)phosphine
(THP) at 37 ˚C. The molar crosslinking ratio of hydroxymethylphosphine (HMP) in THP
to primary amine in RZ-scQK was 50:1. The minimum crosslinking time was screened,
and film stability was confirmed by incubating the film in 0.05% SDS for 24 h at room
temperature before Western blot. The purple color indicates the presence of a THPcrosslinked resilin protein film on the coverglass. The films that had crosslinked for at
least 30 min was stable in SDS, indicating that 30 min may be necessary for complete
crosslinking.
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Figure D.2 Conjugation of resilin-based proteins with sulfo-SANPAH (SS) before
production of photocrosslinked resilin films was confirmed by the trinitrobenzene
sulfonic acid (TNBSA) assay. The RZ-RGD protein containing ten repeats of resilin was
conjugated with SS for 4 h. The percentage of conjugated lysines in RZ-RGD with SS
increased as the molar ratio of SS to amine groups in RZ-RGD increased. Numbers in
each bar represent the percentage of lysines conjugated to SS. Letters indicate statistically
different Tukey groups.

Figure D.3 Photocrosslinking of resilin-based proteins conjugated with SS was confirmed
by fourier transform infrared (FT-IR) spectroscopy. The RZ-RGD protein was conjugated
with SS at a molar ratio of 2:1 (i.e., SS: amine). The solution of RZ-RGD conjugated
with SS was placed in silicone molds on a microscopy slide and dried overnight at 50-60
˚C. The dried protein (RZ-SS) film was exposed to UV light for 3 h. The azido
characteristic peak at 2130 cm-1 was reduced in +UV film compared to –UV film,
indicating that photocrosslinking of the RZ-SS film occurred under UV light.

122
Appendix E

Additional Protocols

Flow Cytometry: Staining for endothelial cell markers on MSCs and HUVECs
0. Prepare filtered 1x PBS containing 0.5% BSA (5 mg/mL)
1. Reserve the machine before you do experiment
2. Detach cells from plates, count cell number, and distribute 100,000 cells per sterile 1.7
mL Eppendorf tube
3. Pellet 1 x105 cells at room temperature at 500 g for 5 min for each staining condition.
4. Remove the supernatant by pipettes and resuspend in 100 µL of 1x PBS containing 0.5%
BSA
From this point on, procedure is in dark
5. Save one tube as unstained cells. If you have cells that have grown in multiple
conditions, you should have unstained cells for individual group
6. Add the appropriate amount of antibody to each tube, mix by pipetting and a quick
pulse vortex, and incubate on ice for 20 min
a. For

proper

selection

of

antibody,

contact

Dr.

Jeffrey

Woodliff

(jwoodlif@purdue.edu) in Bindley.
b. Each antibody vial comes with a recommended amount to use, but the antibody
concentration can be screened. In this case, design your experiment first with Dr.
Woodliff.
c. For HUVECs and endothelial-like cells (screened by Yeji Kim on November
2013)
Marker name-fluorochrome/volume to use (screened)/recommended volume
CD31-FITC (PECAM)/1.25 µL/5 µL (Biolegend, 303104)
CD34-PE/5 or 10 µL/5 µL (Biolegend,343506)
CD144-PE (VE-cadherin)/10 µL/20 µL (Biolegend,348506)
CD309-Ax647 (VEGFR-2)/5 µL/5 µL (Biolegend,338909)
LDL/2 µg/mL/10 µg/mL (Biomedical Technologies)
7. Wash once by adding 1mL of PBS/BSA to each tube and pipette up and down.
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8. Spin the cells down, remove the supernatant and resuspend in 0.5 mL PBS/BSA (for 5
mL tubes)
9. Bring stained cells on ice in DARK to Bindley
10. Run FC500
11. For training, contact Jill Hutchcroft (Hutchcroft@purdue.edu)
FC500 in Bindley Bioscience Center Room 233 (Program: MXP cytometer)
1. Place 5 mL tube containing 500 µL of unstained cells on the rack. The rack should be
placed properly in the holder (THIS IS THE MOST IMPORTANT THING!)
2. For setting with unstained cells, go to cytometer control.
a. Open your protocol (example: Yeji Kim)
b. Go to cytometer control
i. If you need red laser, click laser enabled under ―Red laser shutter‖
ii. They have two lasers: Argon ion laser (488 nm) and Red solid state HeNe
laser (631 nm)
iii. Click Quickset (The bars will show up. These adjust voltage in PMT)
iv. Click Setupmode (this is for setting. Once you find the best setting for my
samples, you should UNCLICK Setpupmode before you run your actual
samples
v. Press close
c. Go to Plate Wizard
i. Clear plate
ii. Click a well containing unstained cells
iii. Select your protocol (Yeji Kim) and draw it to the plate
iv. Check whether plate (rack) type is ―40 tube‖
v. For setting, volume: 50 µL and max event: 5000
vi. Press OK.
d. Press Run
i. Adjust setting (x and y axis) to see your cells on the magnitude of 1 (up to
100)
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ii. Abort the plate to finish setting.
3. Now, you are ready to run your samples.
a. Go to Cytometer control
i. Unclick Setupmode
ii. Set Max to 10,000 events for 100,000 cells per sample
iii. Set duration time to 300 s
b. Place your samples on the rack (plate). Unstained cells should be run first.
c. Go to Plate Wizard
i.

Assign samples with my protocol (Yeji Kim)

ii.

Change volume to 250 µL

d. Press Run button.
e. While they are running, keep monitoring program to check whether event number
is increasing. If there are some clots or you don‘t have cells, the event number
won‘t be increasing.
Production of THP-crosslinked resilin-based protein film
1. Adsorb RZ proteins at 1 mg/mL in PBS on acid-cleaned cover glasses overnight at 4
˚C
2. Next day, wash surfaces with PBS three times
3. Place protein-side down on 70 µL THP solution
4. Crosslink adsorbed protein surface with THP at 37 ˚C for 30 min
a. Minimum molar ratio of HMP to amine was screened and determined to be
50:1
b. Minimum incubation time was screened and determined to be 30 min
5. Place coverglasses into new plate and wash with PBS three times
6. To check crosslinking, perform colorimetric Western blot analysis
a. To check the stability of the film, incubate the film in 0.05% SDS for 24 h
before Western blot analysis.
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Conjugation of resilin-based proteins with sulfo-SANPAH
1x buffer: For SS conjugation, the buffer does not necessarily have both HEPES and salts.
The SS solubility decreases as salt concentration increases.
(Note: Pierce said it does not necessarily have salts in the buffer and pH is the most
important)
1) Dissolve 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.24 g KH2PO4 in 900 mL MilliQ
2) Adjust pH to 7.4 with NaOH
3) Fill to final volume of 1L

Sulfo-SANPAH

(N-Sulfossuccinimidyl-6-(4‘-azido-2‘-nitrophenylamino)

hexanoate,

Pierce Biotechnology, Rockford, IL, 490.40 Da):
1. Always work in dark
2. Dissolve Sulfo-SANPAH (SS) and protein in 1x Buffer
a. SS is moisture-sensitive. Equilibrate the vial to room temperature before
opening.
b. If SS is not dissolved well, warm up the solution in water bath at 37 °C. But, do
not leave in buffer too long, otherwise SS will be hydrolyzed.
c. pH of the solution is more important than temperature or salt concentration.
d. Half-life time of NHS-ester
i. 4-5 hrs at 0 °C, pH 7
ii. 1 hrs at 0 °C, pH 8
iii. 10 min at 4 °C, pH 8.6
e. Do not mix SS solution by vortexing. Once they are stuck on the wall, they
don‘t go back into solution well.
3. Add protein solution to SS solution
4. React protein with SS at room temperature for 30 min with stirring (~350 rpm)
a. At 4 °C, react for 2 h
b. If SS is conjugated to proteins, it turns red to orange color.
5. Place reaction mixture onto microscopy slide with silicone mold in the DARK
6. Dry in 40-50 °C oven containing dessicant overnight (Keep DARK)
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7. Before photo-crosslinking, pre-heat 21.7 mW/cm2 of 365 nm light (Blak-Ray B100AP/R, Ultra Violet Products, Upland, CA) for 5-10 min
8. Expose to UV lamp for 2 h
a. Upon UV exposure, SS turns to rust brown.
Measurement of conjugation of resilin-based protein with sulfo-SANPAH: TNBSA
assay (modified from Pierce protocol)
Reaction buffer (0.1 M sodium bicarbonate, pH 8.5): Dissolve 0.42 g sodium bicarbonate
in 50 mL water
1X buffer: 15 mM NaCl, 25 mM Na2HPO4 (pH 7.4)
Note: make a standard solution every time you do the assay.
TNBSA is toxic. Work in the hood.
1. Dissolve RZ proteins into the reaction buffer (RB) or 1X buffer directly
a. Standard concentration: 0-2000 µg/mL (The minimum: ~ 25 µg/mL)
b. Check pH of the buffer before use
c. There is no difference in the slope of standard between reaction buffer and 1X
buffer
2. Make a 0.1 (w/v) % working TNBSA solution
a. Dilute 5% TNBSA (stock in -20 °C) by 50 in the reaction buffer and mix well
b. Work in the hood
3. Add 0.25 mL of 0.1% (w/v) TNBSA working solution into the 0.5 mL of RZ-SS
solution (or standard) and mix well.
a. Since SS has background absorbance at 355 nm, react only SS solution (no
conjugation with RZ) at the same concentration of SS in RZ-SS with TNBSA
working (serve as blank for RZ-SS)
4. Incubate them at 37 °C for 2 h with gentle shaking (~110 rpm)
5. To each sample, add 0.25 mL 10% SDS to prevent protein precipitation and 0.125
mL of 1N HCl to stop the reaction.
a. TNBSA working: protein sample (or standard): SDS: HCl = 2:4:2:1
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b. Do not use higher concentration HCl (e.g. 6M) because SS in SS-RZ solution is
precipitated.
c. If you don‘t want to stop the reaction, measure the absorbance at 420 nm.
6. Measure the absorbance at 355 nm of each sample (150 µL per well of a 96-well UV
plate). If the absorbance is over 0.8, dilute the samples by 8 with ‗reaction
buffer+TNBSA+HCl‘, in order to keep the absorbance value ranging from 0.2 to 0.8.
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